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Abstract 
Epizootic haematopoietic necrosis virus (EHNV) was grown in BF-2 cells, purified from 
cell culture material, and tested for cellular contamination by SDS-PAGE, western transfer 
and immunostaining with anti-BF-2 serum. Purified virus was introduced to sheep and 
rabbits to raise antiserum against EHNV. These antibodies were used in the development 
of an antigen capture enzyme linked immunosorbent assay (ELISA) for the detection of 
EHNV in redfin perch and rainbow trout. The ELISA format chosen after many 
optimisation experiments has the ability to detect virus in cell culture to a titre of 10' 
TCIDst/ml. After screening 1,200 tissue homogenates by virus isolation and using the 
tissue homogenates and the culture supematants in an ELISA, positive/negative cutoffs of 
0.95 and 0.75, respectively, were chosen. Although quite high these cutoffs did not affect 
the utility of the test. The sensitivity and specificity of the antigen capture ELISA appear 
more than adequate for diagnostic screening of test samples from fish populations. 
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Chapter 1 - Literature Review 
1.1 General Introduction 
The word "virus" comes from the Latin and literally means a poison (Smith, 1962). 
Although described as an inert poison in early times, it has since been discovered that 
viruses have many characteristics which fit them into the realm of biology. Also, due to 
the Latin derivations of their descriptor it is obvious that they are no modem phenomenon. 
The disease caused by the smallpox virus was described by the Chinese in the tenth 
century before Christ, and the first indisputable scientific evidence of viruses was 
presented in 1892 by a Russian botanist, Ivanovski, for the tobacco mosaic virus. Lwoff 
(1959) proposed that all true viruses have four characteristics: i) they contain only one 
type of nucleic acid; ii) they are reproduced from their genetic material and in the form of 
their genetic material; iii) they do not grow and they do not undergo binary fission; and 
iv) they possess no enzyme systems for energy production. The fact that viruses have 
genomes, replicate, evolve, and occupy particular ecological niches distinguishes them 
from chemicals (Van Regenmortel et al., 1992). 
The first fish virus was isolated in 1957, but the first disease caused by a virus in fish, 
fish pox, was described by Konrad Gesner in 1563 (Wolf, 1982). The virus that is the 
subject of this study. Epizootic Haematopoietic Necrosis Virus (EHNV), is a fish virus and 
was first isolated in 1984 (Langdbn et al, 1986), but its presence was suggested before this 
by the mass mortalities of juvenile redfin perch {Perca fluviatilis) that were noted in Lake 
Bumimbeet, western Victoria, Australia, in January 1972. Similar mortalities have been 
recorded in subsequent summers in this and other lakes (Langdon and Humphrey, 1987). 
1.2 Taxonomy and Characteristics of Iridoviruses 
As there are no fossil records of viruses, and because it has been almost impossible to 
experimentally demonstrate their origin, viruses have not been classified with respect to 
their evolutionary trends until quite recently. They have been classified on the basis of the 
type of nucleic acid they possess and on their ultrastructural morphology. There are over 
twenty families or groups of viruses and EHNV is thought to belong to the Iridoviridae 
family (Langdon, 1986). The characteristic features of an iridovirus include: icosahedral 
symmetry; large, linear, double-stranded DNA genome; a cytoplasmic site of replication 
(Murti, et al., 1985). This family is currently divided into five genera: Iridovirus, 
Chloriridovirus, Ranavirus, African swine fever virus (ASFV), and fish lymphocystis 
disease virus (FLDV). Iridoviruses are distributed widely among a variety of vertebrate 
and invertebrate hosts. 
Both the Iridovirus (small invertebrate viruses) and the Chloriridovirus (large insect 
viruses) genera contain iridescent insect viruses, and are described by Kelly and Robertson 
(1973) as large, icosahedral, cytoplasmic, DNA viruses. These viruses tend to colour an 
infected host blue-green, and purified viral pellets (after centrifugation) may also be an 
iridescent blue-green colour. Included in these genera are Tipula iridescent virus (TIV), 
Sericesthis iridescent virus (SIV), mosquito iridescent virus (MIV), and Chilo iridescent 
virus (CIV). Although extremely similar in most physical and biological properties, these 
viruses are not identical (Kalmakoff and Tremaine, 1968). 
The genus Ranavinis contains viruses that infect amphibians and the best studied member 
is Frog Virus 3 (FV3). Willis et al. (1985) stated that FV3 is a cytoplasmic DNA virus 
probably similar to or identical with the other known amphibian viruses that have been 
isolated from bullfrogs, newts and toads. FV3 possesses icosahedral symmetry, has a 
diameter of 160-200nm, and enveloped and unenveloped particles. It contains a single, 
linear, double stranded DNA genome with methylated cytosine in particular base 
sequences. Restriction mapping, partial denaturation and reannealing, however, show that 
the DNA is circularly permuted, with variable length single stranded tails ie: terminally 
redundant (Murti et al., 1985). Kelly and Avery (1974) showed by DNA hybridization 
studies that there was no sequence homology between FV3 and other iridoviruses. 
FLDV occurs worldwide and causes a chronic disease, lymphocystis (nodular skin 
lesions), in several higher order salt, brackish and fresh-water fish species (Flugel, 1985). 
It has been reported in 125 species representing 42 families of fish (Pearce et al., 1990), 
and is an icosahedral particle with a diameter of 130-300 nm. The DNA is double 
stranded and linear (Darai et al., 1983). The virus has a bilaminar capsid with a 
filamentous core and replication occurs in the cytoplasm of cells. Other piscine viruses 
thought to belong in the Iridoviridae include; piscine erythrocytic necrosis virus, carp gill 
necrosis virus, cod ulcer syndrome virus and goldfish virus (Langdon et al., 1986). 
Essani and Granoff (1989) suggested a new nomenclature and taxonomy for amphibian 
and piscine iridoviruses based on molecular and biological properties. The viruses chosen 
for the study were the amphibian iridovinises, FV3, LT-1, tadpole eodema virus (TEV), 
and a goldfish iridovirus (GFV). FLDV has no homology with any of the Ranaviruses and, 
therefore, was not included in the study. FV3, LT-1, and TEV were found to be closely 
related with a 90% homology after restriction enzyme analyses and nucleic acid 
hybridisation. However, only 24% of radioactive FV3 DNA hybridised to GFV, 
suggesting only a distant relationship and there were also differences in base methylation. 
It was thus proposed that FV3, LT-1, and TEV be classified as Ranaviruses, and the 
piscine iridoviurses be divided into two genera: FLDV and GFV, due to the difference in 
size and sequence morphology. 
Last but not least is AFSV, which can be tickbome, but is also highly contagious by 
simple contact. The virus causes African swine fever in domestic pigs in a number of 
countries, excluding Australia (Vinuela, 1985). This disease usually results in death of 
affected pigs. The virus is an enveloped, icosahedral, DNA virus with a diameter of 200 
nm (Mebus, 1988). Although ASFV particles and their assembly in the cytoplasm of 
infected cells are typical of the Iridoviridae family, they also share some molecular 
characteristics with the poxviruses. For example, the DNA of both the poxvirus and ASFV 
have covalently closed ends and terminally inverted repetitions, and both have complex 
and icosahedral symmetry respectively (Vinuela, 1985). 
1.3 Structure and Classification of Epizootic Haematopoietic Necrosis Vims 
Devouchelle et al. (1985) state that the Iridoviridae are by far the largest of the known 
icosahedral viruses, with reported diameters ranging from 120-300 nm. There are many 
other structural and morphological similarities among the five genera of the Iridoviridae. 
For instance, they have an icosahedral shape, surface structural subunit aggregates, an 
inner unit membrane, and usually an electron dense core. The core contains double 
stranded DNA (Matthews, 1979). Replication always takes place in the cytoplasm of 
infected cells and release occurs by cell lysis or budding through the cytoplasmic 
membrane. 
When examined under the transmission electron microscope, Langdon et al. (1986) found 
that EHNV particles ranged in size from 148-167 nm in diameter. They are found only in 
the cytoplasm of infected cells where they frequently formed stacked or crystalline arrays. 
They have a spherical nucleoprotein core surrounded by an icosahedral membrane capsid, 
and envelopes are formed by budding from the endoplasmic reticulum and plasma 
membrane, but are not present on viral particles lying in the cytoplasm. 
EHNV thus was classified as an iridovirus on the basis of its size, its icosahedral 
morphology, the presence of viral inclusion bodies and viral particles in the cytoplasm of 
infected cells, and sensitivity of the virus to ether. Ether dissolves lipid membranes, so a 
sensitivity to ether suggests that the virions are enveloped (Langdon et al., 1986). Eaton et 
al. (1991) state that EHNV is closely related to FV3 on the basis of similarities in the 
number and complexity of proteins in purified virus particles, morphogenesis within 
cytoplasmic inclusion bodies, and association of both viruses with the cytoskeleton of 
infected cells. 
1.4 Virus Purification Procedures for Iridoviridae 
Although there are many procedures available for the purification of viruses Devauchelle 
(1985) pointed out that a number of iridoviruses have been purified using density gradient 
centrifugation in sucrose. These methods usually yield two bands, the lower band 
representing intact virions, while the upper one consists of less dense particles which 
retain their icosahedral form. The particles from the upper band are not permeable to 
negative stains, tend to disrupt during negative staining, and contain less nucleoprotein 
(Stoltz, 1973). When this study commenced EHNV had not been purified previously, and 
a goal of this study was to develop a satisfactory purification procedure for EHNV. 
The purification of TIV has been described by Kalmakoff and Tremaine (1968), and MIV 
by Matta (1970). Both methods utilised differential centrifugation in conjunction with 
sucrose density gradients, followed by dialysis against phosphate buffer to remove sucrose 
and concentration with high speed centrifugation. Two distinct components were revealed 
after two cycles of differential centrifugation: the "top component" (amorphous, 
non-infectious mass when pelleted) and a bottom component (infectious, green to red 
iridescent pellet). Glitz et al. (1968) used similar methods to purify TIV and SIV and these 
methods revealed the two bands described above. 
The purification protocols for FV3 also yielded two bands after gradient centrifugation. 
FV3 is usually grown in baby hamster kidney cells (BHK) for 3 - 4 days before the cells 
are collected, treated ultrasonically, and centrifuged at low speed (1,500 g for 15 min) to 
remove cell debris. Aubertin et al. (1973) pelleted the virus at high speed (45,000 g for 45 
min), resuspended the pellet in lOmM Tris-HCl pH 9, briefly ultrasonicated the 
resuspended material, and centrifuged this through a 43% sucrose cushion, before loading 
the pellet onto a 1 0 - 4 0 % sucrose gradient. The viral band was sedimented at high speed 
and sometimes reloaded onto a 2 0 - 4 0 % CsCl gradient for further purification. Aubertin et 
al. (1980) pelleted the virus through a 36% sucrose cushion at 90,000 g for 4 hrs, 
resuspended the preparation in 10 mM Tris-HCl pH 8.5, and centrifuged this through a 
1 0 - 4 0 % sucrose gradient (25,000 g for 45 min). The virus band was collected, 
resuspended and centrifuged through a 35 -65% sucrose gradient. On the other hand. Tan 
and McAuslan (1971) simply layered the tissue culture supernatant over a 2 0 - 6 5 % 
sucrose gradient and centrifuged at 30,000 g for 20 min to recover two bands which were 
distinct, from cellular, material and thus pooled. The pooled bands were layered over a 
4 0 - 8 0 % gradient of sucrose, or potassium tartrate or CsCl gradients in R S B buffer (0.01 
M Tris-HCl, 15 mM MgCl^, 0.01 M KCl, pH 8) and centrifuged at 109,000 g for 4 hrs to 
further purify the virus. 
Darai et al. (1983) and Flugel et al. (1982) described similar methods for the purification 
of FLDV which were modifications of methods outlined by Parr et al. (1977). In both 
methods, 1 - 5 g of lymphocystis tissue was homogenised and clarified by low speed 
centrifugation (3,000 g for 20 min). The virus was then pelleted through a 30% sucrose 
cushion, resuspended in TNE buffer (0.05 M Tris-HCl, 1 mM EDTA, 0.1 M NaCl, pH 
7.4), and loaded onto 2 5 - 6 0 % sucrose gradients and centrifuged at 25,000 rpm for 20 hrs 
in a Spinco SW27 rotor. The viral band was collected and centrifuged again at high speed 
(30,000 rpm for 24 hrs in a Spinco SW41 rotor) on a 10-35% CsCl gradient. The viral 
band in the centre of the gradient was collected and dialysed against TNE buffer. 
Black and Brown (1976) passaged and grew ASFV in monolayers of pig kidney cells 
(PK15 cells and IBRS-2 cells). The virus was then pelleted at 60,000 g and resuspended 
in 0.05 M Tris-HCl pH 7.2 with 1 mM EDTA by sonicating in a water bath sonicator, 
before being loaded onto a 15-45% sucrose gradient to separate the virus from cell 
debris. 
It appears, from these methods, that iridoviruses are generally stable for sonication, high 
speed centrifugation and in sucrose. 
1.5 Laboratory Diagnosis of Viral Diseases 
Sensitivity, specificity, repeatability (precision), convenience, cost, and availability are 
some of the criteria which need to be assessed when choosing a diagnostic assay. Of 
these, sensitivity and specificity are often the most important. Assay sensitivity is the 
ability of the test to detect small amounts of the antigen, or antibody to a specific antigen, 
under evaluation. In an epidemiological context, sensitivity is defined as the proportion of 
animals with the disease that test positive. Specificity is the ability of the assay to detect 
only the target compound, or in an epidemiological sense, the proportion of animals 
without the disease which test negative (Baldock, 1988). In viral diseases it is necessary to 
be able to recognise the presence of viruses and also to identify the specific virus in a 
diseased host. The applicability of a diagnostic test to a disease control programme 
depends on its epidemiologically defined sensitivity and specificity evaluated in relation to 
the prevalence of the disease, the economic cost of the disease and the cost of the test. 
The complexity of both the animal body and microbial pathogens results in a spectrum of 
possible outcomes following microbial infection. When diagnosing disease in animals 
many factors need to be considered in order to arrive at the correct diagnosis. Some of 
these are discussed below. 
History of the animal population needs to be assessed to give clues on where the disease 
may have come from. Management, age of fish, stocking rates, water temperatures, and 
other environmental factors may all play a part in a disease affecting a particular fish 
population. 
Before laboratory diagnosis, the critical point in any investigation of animal disease is the 
clinical investigation of the animal or group of animals. Some abnormal manifestation in 
the host usually indicates the presence of disease, a viral disease in this case, but some 
viruses may infect a host and persist without causing any signs of disease. Clinical signs 
are observed at the level of the affected organism, but are due to tissue cellular 
dysfunction. Blood and Radostits (1987) show many case studies which indicate the value 
of assessing clinical signs when making a diagnosis of disease in animals. 
Pathology of organs also gives^ valuble clues as to what the disease may be. Gross 
abnormalities observed in a necropsy specimen and microscopic pathology observed by 
light or electron microscopy are both useful aids in diagnosis. Some infectious agents 
cause characteristic tissue pathology which may be examined after histologically treating 
the specimen. Blood and Radostits (1987) illustrate many examples of abnormalities in 
tissue pathology caused by many different infectious agents. 
An extremely useful technique for the detection of viruses is virus cultivation on 
monolayers of cells in vitro. Cells can either be derived directly from animal tissues 
(primary cultures) or from established lines of cultivated cells (sometimes called 
permanent cultures). Infection of such a cell monolayer with a sample suspected of 
containing virus may give a typical cytopathic effect (CPE), consisting of cell destruction, 
proliferation or morphologic alteration (Luria and Darnell, 1968). If, after inoculation with 
material containing the virus, the cell layer is overlaid with nutrients solidified in agar, the 
virus will be restricted to spreading among contiguous cells and local lesions or plaques 
will result (Dulbecco, 1952). 
When first obtained from a naturally infected host, many viruses may not grow well in the 
available experimental host cell culture systems. A process of adaptation may have to be 
undertaken. Adaptation consists of the selection of viral variants capable of multiplying in 
the new host cell type. Host specificity is controlled by the genetic properties of both the 
virus and the host cell. Serial transfers through successive hosts or serial inoculations in 
tissue cultures, coupled with serological tests and/or electron microscopy, should reveal the 
virus. 
The development of the electron microscope (EM) in 1931 by Ruska and Knoll was a 
significant contribution to present day concepts of vims morphology (Gratzek, 1969) and 
is now used routinely in viral diagnosis. 
Negative contrast electron microscopy (NCEM) is the technique most often used in 
diagnostic EM laboratories. The clinical specimens are treated to remove extraneous 
material and precipitate (or "fix") the protein. The viral preparations are adsorbed to a 
copper grid and negatively stained with heavy metal solutions (for example, 2% 
phosphotungstic acid, pH 6.5). 
Immuno-electron microscopy (lEM) has also developed to the point where immuno-gold 
procedures are considered routine. Viruses are adsorbed to a grid, and an antiviral 
antibody is added. This antibody may or may not be conjugated to colloidal gold. If it is 
not then it must be followed by a gold labelled protein A or protein G, or a secondary 
gold-labelled antispecies antibody (the "conjugate"). If the number of virions present is 
low, then the grid-cell-culture technique (Hyatt, 1989) may be used; the virus is amplified 
in cell culture, then grown in-situ on the grid in a cell monolayer. Thin sectioning of 
tissue culture embedded in resin is also useful, but is time consuming (Hyatt, 1989). 
All vertebrate animals have an adaptive immune system which provides protection against 
infectious organisms and the toxins they produce (Harlow and Lane, 1988). These 
organisms or toxins, usually termed antigens (Ag), are foreign to the animal and stimulate 
the immune system to produce proteins which bind specifically to the foreign molecules. 
These proteins are known as antibodies (Ab). All antibody-antigen reactions involve a 
specific combination of the two reagents. This specificity renders the serological reaction a 
fine tool for analysing antigens (Luria and Darnell, 1968). Virus particles possess 
antigenic properties and generally produce an immune response in animals they infect. 
Immunological reactions can thus be used for diagnosing, identifying, and characterising 
viruses. 
A number of antibody-antigen reactions are possible, depending on the physical properties 
of the antigen and the antibody. When an antigen is added to an homologous antiserum, 
changes in the state of dispersion of the antigen occur, for example; precipitation or 
agglutination. Agglutination, however, is not suitable for viruses as it is restricted to larger 
antigens of a cellular nature such as bacteria or red blood cells that are able to form a 
visible reaction at the gross or light microscope level. In a precipitation reaction, 
individual molecules of antigen are held together by antibody molecules in a lattice or 
framework. Diffraction of light by the precipitate causes visible banding with appropriate 
illumination. This reaction has an equivalence point and if there is an excess of either 
antigen or antibody, precipitation may fail to occur. Precipitation reactions may take place 
in liquid medium in test tubes or by diffusion in agar/agarose gel plates and are highly 
suited for detection of soluble antigens and small particles such as viruses. 
Complement fixation is another class of immunological reaction. This is essentially an 
indirect means of indicating that an antibody-antigen reaction has occurred. In this assay 
the forming aggregates of an antibody-antigen reaction bind complement (a heat labile 
normal fraction of serum (Luria and Darnell, 1968)) rendering it unavailable to haemolyse 
the sensitised red cells added as an indicator (Burnet, 1959). In the absence of the Ag-Ab 
reaction, free complement in the system binds to the sensitised red cell (red cell + anti red 
cell antibody), causing haemolysis. 
Neutralisation reactions, as the name suggests, are a class of reaction where infectivity of 
the viral particle is lost or neutralised when the antibody-antigen reaction occurs. This 
suggests that an essential portion of the viral particle, for example a cell binding site, is 
inhibited by the combination with an homologous antibody. 
Another reaction which permits visualisation of viral antigen within the cells is 
immunofluorescence. Immunofluorescence may be carried out either directly or indirectly. 
In the direct method the antiserum is labelled with a dye, and applied to the cells 
containing virus. The excess is washed away and the areas of infection fluoresce under 
UV light and are visualised with a fluorescent microscope. The indirect method includes 
an unlabelled antiserum, followed by a labelled antispecies antiserum. 
The enzyme linked immunosorbent assay or ELISA is perhaps the immunological assay 
receiving the most attention at present due to its sensitivity, specificity, speed, versatility, 
low cost, and reagent stability. The method is similar to those described above for 
immunofluorescence, except the labelled antibody is labelled with an enzyme instead of a 
fluorescent dye, and the reaction is carried out in a a specially formulated plastic 
(polystyrene) 96 well plate. More attention will be given to the ELISA in chapter 4. In 
contrast to agglutination, precipitation, complement fixation, and neutralisation reactions, 
the ELISA is a primary Ag-Ab binding assay. The former systems require the binding of 
antigen to antibody followed by a secondary reaction to detect the first. 
Western blots have recently been found to be a valuable diagnostic tool for some viruses 
as well, but are not used currently for the diagnosis of fish viruses. 
1.6 Epidemiology and Pathogenesis 
The signs of infectious disease are the result of the action of certain chemical components 
of the infecting organism on the tissues of the host. Virulence or pathogenicity is the 
ability of the microorganism to infect the host and cause a disease. Pathogenic viruses are 
transmitted from infected to susceptible animals in a variety of ways. The majority of 
infections are transmitted by direct or indirect contact with animals harbouring the disease. 
Some viruses are very persistent in the environment, and these may then become a 
reservoir of infection. The term epidemiology embraces the history and behaviour of the 
disease in a population (Boddie, 1962). 
Epidemiology is defined as the study of the patterns of disease that exist under field 
conditions, or more specifically the study of the frequency, distrbution, and determinants 
of health and disease in populations. Epidemiological studies are undertaken with the 
primary purpose of providing data on which a rational decision for the prevention and/or 
control of disease in animal populations can be based (Wayne Martin et al., 1988). 
There is only limited information concerning the epidemiology and pathogenicity of 
EHNV. EHNV was first isolated from Redfin perch (Perca fluviatilis) from Lake 
Nillahcootie near Benalla in Victoria in 1984 (Langdon et al., 1986). The virus is 
responsible for mortalities of up to 100%, including all age classes of fish (Langdon and 
Humphrey, 1987). Outbreaks in juvenile fish are more common and are usually confined 
to late spring and early summer. Clinical signs include spiralling movements and slow 
surface swimming, along with listlessness and ataxia. Pathological signs include reddening 
around the brain and nostrils, haemorrhages at the base of the fins and cutaneous ulcers, 
and ascitic fluid may also be present in the abdominal cavity. Histological studies 
consistently shows necrotic changes in a variety of tissues, with the most severe lesions 
being in the renal haematopoietic tissue, spleen and liver. Infected tissue culture cell 
monolayers develop a cytopathic effect (CPE) in the form of focal rounding of cells and 
holes in the cell layer. This can occur within 1 - 5 days after inoculation with EHNV. 
Apparently healthy redfin, when experimentally inoculated with EHNV, succumb to 
infection and have similar pathology to naturally infected fish (Langdon, 1989) and the 
virus can be re-isolated. This fulfils Koch's postulates. 
Wolf (1988) has described most viral diseases of fish in great detail. Many of the clinical, 
external and/or internal symptoms of other fish viral diseases are similar to those of 
EHNV. Some viral diseases of salmonids with similarities to EHNV include: 
Infectious haematopoietic necrosis (IHN) which is an acute, systemic and usually virulent 
rhabdoviral disease. It mainly affects young trout and some salmon under husbandry with 
the most obvious sign being high mortalities in fry and fingerlings usually at a water 
temperature of about 12°C. Fry also become lethargic with intermittant frenzied action. 
Externally, the fry are much darker than normal and haemorrhagic at the fin bases. 
Internally, appearance is anaemic and the body cavity may contain ascitic fluid. 
Histopathologically, the major necrotic changes occur in the kidneys, haematopoietic 
tissues, pancreas, the gastrointestinal tract and the adrenal cortex. 
Infectious pancreatic necrosis (IPN) is an acute, contagious, systemic bimavirus disease of 
fry and fingerling trout. In hatchery trout the infection ranges in virulence, causing 100% 
mortality in some cases and no losses in other cases. Alternate prostration and whirling is 
typical. External darkening also occurs, and abdominal distention and ventral 
haemorrhages are common. Internally petechial haemorrhages in the viscera occur, 
however, more typically the liver, heart, spleen and kidneys become very pale, and the 
body cavity may contain ascitic fluid. Pancreatic necrosis is produced with other 
histopathological changes occurring in the adipose tissue and renal haematopoietic tissue 
and also in the gut and liver. 
Viral haemorrhagic septicemia (VHS) is an acute to chronic viscerotropic disease caused 
by a rhabdovirus, usually in husbandry. In water temperatures less than 10°C outbreaks 
causing severe mortalities may occur in trout fingerlings and yearlings. Typically, affected 
individuals do not feed and alternate rapidly between lethargy and hyperactivity. 
Externally, darkening occurs and haemorrhaging may also affect the fin bases. Internal 
signs range from profuse bleeding in the organs and body cavity, to just a pale, mottled 
liver, dark kidneys, and enlarged spleen. Degenerative changes and necrosis are common 
histopathological signs in many tissues, with kidneys being the main target. 
Koch's postulates for confirmation of a causal role for a microbe in a disease syndrome 
are: 1. show that the microbe is regularly found in diseased hosts; 2. cultivate it in 
suitable media; 3. reproduce the disease in experimental animals by means of cultures of 
the microbes; and 4. re-isolate the microbe from artificially infected hosts. For diagnosis 
of viral diseases the postulates described by Rivers (1937) become: 1. isolation of virus 
from diseased hosts; 2. cultivation in experimental hosts or host cells; 3. filterability to 
exclude bacteria and other pathogens; 4. production of a comparable disease in the original 
host species or in related ones; and 5. re-isolation of the virus. 
The main aims of this project therefore are to: 
i. Purify EHNV, 
ii. Raise antibodies against the purified virus in sheep and rabbits, 
iii. Develop an antigen capture ELISA for the detection of EHNV in redfin perch and 
rainbow trout, 
iv. Develop a procedure to release virus from fish tissues as efficiently as possible, 
V. Establish the specificity and sensitivity of the ELISA. 
2. Chapter 2 - General Materials and Methods 
2.1 Materials 
* Bluegill fry (BF-2) cells (American Type Culture Collection, reference number CCL91) 
* Minimal essential medium Eagle, with Earle's salts and glutamine (MEM), (Flow 
Laboratories, Sydney, Australia) 
* EHNV (culture supernatant of EHNV isolated from rainbow trout, from Australian 
Animal Health Laboratories, Geelong, Victoria) 
2.2 Cell Culture 
BF-2 cells arrived in frozen ampoules. These were thawed and centrifuged at 800 g for 10 
min to remove dimethyl sulphoxide (DMSO), resuspended in a small volume of growth 
medium (MEM + 10% foetal calf serum (FCS) + 100 U/ml each of penicillin and 
streptomycin + 2 ng/ml amphotericin (Fungizone)). More growth medium was then added 
to the cells so that tissue culture bottles (1 L, or 170 cm', Flow Laboratories, Sydney, 
Australia) (Flow bottle) were seeded with approximately 1 x 10^ BF-2 cells in 100 ml 
each of growth medium and incubated at 24°C until the monolayer was confluent (approx 
4 days). The medium was removed and cells trypsinised with 140 mM NaCl, 5 mM KCl, 
7 mM NaHCOj, 2.5% glucose, 1.25% trypsin, 1 mM EDTA and 5,000 U penicillin and 
streptomycin (P/S) (this buffer is called ATV), centrifuged, and resuspended. Some were 
resuspended in growth medium + 10% DMSO so that a stock could be frozen down at -
80°C, and the rest were resusupended in growth medium to seed Flow bottles that were 
again incubated at 24°C. As a general rule one Flow bottle with a confluent monolayer of 
BF-2 cells could be split to seed 4 x 96 well microtitre plates for titrations, or 1 rack of 
virus isolation tubes (96 x 10 ml tubes), or 4 Flow bottles. Maintenance medium is the 
same as growth medium except it only contains 2% FCS. 
2.3 Gel Diffusion Tests 
Borate gel (0.05M NaOH, 0.07M H3BO3, 0.01% NaN,, 1% Seakem agarose) plates were 
poured in 9 cm diameter petri dishes (Hardie Healthcare, Oakleigh, Vic). Wells (2 mm 
diameter) were punched in the gel using a template, so that they were approximately 6 
mm apart. Antigen (6 ^1) was placed in the central well and antisera (6 \x\) to be tested 
was placed in the surrounding wells. Plates were left in a humid atmosphere in the dark 
for 16-24 hrs and then read over a fluorescent light box. A precipitate band forms 
between the two wells if the antiserum does possess antibodies against that antigen. 
2.4 Preparation of Stock Viruses 
A Flow bottle was seeded with BF-2 cells as above. These were incubated at 24°C until 
almost confluent, usually 2-3 days, the medium was poured off and 500 \il of the EHNV 
virus isolate was added. Virus was adsorbed at room temperature for 1 hr with gentle 
rocking every 10-15 min. Fresh maintenance medium was added (100 ml) and the culture 
was then incubated for 3-4 days at 22°C, or until the cytopathic effect (CPE) had 
destroyed the monolayer. The cells and medium were poured off and centrifuged at 2,000 
rpm (900 g) for 10 min to remove cell debris. The supernatant was aliquoted into 5 ml 
volumes. A proportion of the supernatant was stored at -20°C and the rest at 4°C. 
2.5 Virus Titrations 
The virus titrations were carried out using the method of Reed and Meunch (1938). This 
involved serially diluting the virus in media, either in two fold or ten fold dilutions, to 
1:256 or 1:10* respectively. Growth medium was added to microtitre plates (Linbro, Flow 
Laboratories, Sydney, Australia) at 50 |a,l/well, B F - 2 cells (concentration of 75 x 10') were 
added at 100 jxl/well, and then the diluted virus was added at 50 ^il/well, with 8 replicas 
each of 8 dilutions. Microtitre plates were sealed, usually with a sheet of plastic cling 
wrap (Cling wrap, NSW Government stores) incubated at 22°C for 7 days, and read under 
a light microscope. 
3. Chapter 3 - Growth and Purification of EHNV 
3.1 Introduction 
For the successful purification of any virus some prior knowledge of the properties of that 
virus is required, as is a system for the production of a sufficient quantity of the virus. 
The latter requires a suitable host system that can be maintained unchanged. In general 
tissue culture systems are preferred over in vivo culture. Knowledge as to whether the 
virus is predominantly intracellular or is readily released into the culture medium is 
required. If the virus is highly cell associated then consideration must be given to 
releasing methods, for example, natural cell lysis, mortor and pestle, blender, homogenizer, 
osmotic shock, sonication, lysozyme or freeze-thaw. Further, an understanding of the pH 
stability of the virus is important, and an appropriate buffering system should be 
developed for crude virus preparations to maintain stability as some of the materials they 
come in contact with when released from cells may cause instability (inactivation) or 
aggregation. 
All purification procedures depend on selection of virus particles homogeneous with 
respect to sedimentation rate (size, shape, and density), electric charge, adsorption 
behaviour, or some other physical or chemical property (Sharp, 1953). Chromatographic 
methods that have been used successfully in virus purification include calcium phosphate 
chromatography, which is reliant on chemical properties of the surface of the virus, and 
ion exchange chromatography, which utilises the natural negative charge of some viruses. 
The molecular sieve technique, or gel filtration chromatography, has also been successfully 
employed to purify viruses. Gel filtration columns may be packed with agar, agarose, 
dextran, Polyacrylamide gel, or porous glass particles (Ackers and Steere, 1967). This 
technique differs from adsorption, partition or ion exchange chromatography in that the 
elution positions are primarily dependent on the gross size of the virus rather than surface 
or charge characteristics. 
Although the actual mechanism of action of organic solvents is still unresolved (Philipson, 
1967), they can be useful for the purification of nonlipid viruses, which are insensitive to 
denaturation in organic solvents such as chloroform, ether, fluorocarbons, and butanol. The 
solvent creates a strong tension at the interface of two-phase systems (gasAiquid or 
aqueous/organic) and this results in denaturation and eventually virus inactivation. 
However, it is thought (Adams, 1948) that the inactivation may be counteracted by neutral 
proteins which compete with the virus for available surface at the interface, thus the host 
proteins could be denatured leaving intact viruses. Bachrach and Schwerdt (1952) used 
butanol to remove protein impurities in the purification of poliovirus and Polsen and 
Selzer (1954) used chloroform-amyl alcohol treatment to purify poliovirus from tissue 
components. Two liquid aqueous phases can be obtained by dissolving two different 
polymers (dextran, polyethylene glycol, methyl cellulose, or dextran sulfate) in water or 
the virus containing culture supernatant to give a phase system with a phase that is small 
in volume and contains most of the virus activity (Albertsson, 1967). If the virus being 
purified is large then it may collect at the interface. The phase system can result in 
concentration as well as purification. 
One of the most useful techniques for purification of viruses, however, is centrifugation. 
Particles that differ from each other by an order of magnitude in sedimentation rate can be 
separated using alternate cycles of high and low speed centrifugation; this is referred to as 
differential centrifugation. The rate at which particles sediment depends on: their size, 
shape, and density; the centrifugal force, and; the viscosity and density of the suspending 
medium. Density gradient centrifugation is a zonal separation method with sucrose, 
glycerol, or salts such as caesium chloride, rubidium chloride, or potassium tartrate being 
the materials most commonly used to form the gradients (Cramer, 1964). Isopycnic or 
equilibrium density gradient centrifugation occurs when regions of the gradient column 
have densities close to those of the particles being separated and centrifugation is 
optimised (time, g force) to allow particles to reach the equilibium. 
At the time this work was undertaken there were no reports on purification procedures for 
EHNV. Several papers (Tan and McAuslan, 1971; Aubertin et al., 1973; 1980; and 
Braunwald et al., 1979), however, describe the purification of FV3 which appears to be 
the virus most closely related to EHNV. Each of these methods uses sonication for virus 
release and both differential and density gradient centrifugation. These methods were used 
as guidelines to develop a purification procedure for EHNV which is described in this 
chapter. 
3.2 Materials and Methods 
3.2.1 Growth of EHNV - General 
Confluent monolayers of BF-2, RTG (Rainbow trout gonad), and FHM (Fathead minnow) 
cells were produced in 150 cm^ tissue culture flasks (Crown Coming, Sydney, Australia). 
This required 3-5 days incubation at 24"C (28°C for FHM cells) with 50ml each of the 
same growth medium (section 2.2). Each flask was inoculated with 0.3ml of stock virus 
suspension (Rainbow trout isolate; 86:8774) containing approximately 10' TCIDjo/ml 
corresponding to a multiplicity of infection (MOI) of 1.2xl0"\ and incubated at 24°C. 
Development of cytopathic effect (CPE) was monitored, and titrations were done on 
supematants from flasks which contained CPE using the method of Reed and Meunch, 
(1938) (see section 2.5). 
3.2.2 Effect of temperature on the growth of EHNV 
a. Six 25 cm^ tissue culture flasks were seeded with BF-2 cells to give 90% confluency 
over night at 25°C. The media was then removed and 300 î l of the rainbow trout isolate 
of EHNV (86:8774) was adsorbed in each of the flasks for 1 hr, before 50 ml of fresh 
media was added. Two flasks were placed at 25''C, two at 20°C and two at 15°C, left for 
24 hrs, and then 200 [il aliquots were taken twice daily from flasks at each temperature. 
Each aliquot was freeze/thawed three times in liquid nitrogen and a 3TC water bath 
respectively to release virus fronv the cells which had come away from the monolayer with 
increasing time post infection. The supematants were titrated in BF-2 cells using the 
method described in section 2.5. The monolayers were examined under the light 
microscope at the time each aliquot was taken. 
b. Two rainbow trout isolates of EHNV (isolate 1 and isolate 2) were prepared as 
described in section 2.4 and were titrated (see section 2.5) in triplicate so each isolate 
could be incubated at three different temperatures, 22°C, 27°C and 30°C (that is, one plate 
of each isolate at each temperature and thus six plates in total), and read 6 days later. 
BF-2 cells were used. 
c. Kimax tubes were seeded with BF-2 cells. When almost confluent the monolayers were 
inoculated, in triplicate, with five rainbow trout isolates of EHNV, which were prepared as 
descibed in section 2.4. One tube of each stock was placed at each of the temperatures, 
22''C, 27'̂ C and 30°C. 
3.2.3 Purification of EHNV 
3.2.3.1 Method 1 
All g forces quoted in this section were calculated using radius (r) maximum for the 
specific rotor used. 
Ten Flow bottles were seeded with BF-2 cells, and incubated and inoculated as in section 
3.2.1. Cells and virus were harvested by pouring the culture fluid into 1 L centrifuge 
tubes, which were centrifuged at 2,000 rpm (900 g) for 30 min in an MSE Mistral 6L 
centrifuge. The pellets were resuspended in 2 ml of the supernatant, sonicated (Branson 
Sonifier Cell Disruptor - B15,' Branson Co, USA) for three 1 min cycles, and then 
centrifuged at 2,000 rpm (900 g) for 20 min in the SS34 rotor of the Sorvall RC-5B. The 
pellets were resuspended in 2 ml distilled water, left at 4°C for 1 hr, and re-sonicated for 
a further three 1 min cycles. Centrifugation was repeated as above and pellets discarded. 
The supematants were pooled and clarified at 18,500 rpm (45,000 g) for 45 min in 35 ml 
tubes in a Sorvall RC-5B centrifuge. Pellets were resuspended in 2 ml 100 mM Tris-HCl, 
pH 8.6, and loaded onto two discontinuous (step gradients of 10%, 20%, 30%, and 40% 
w/v sucrose, left overnight to equilibrate) 10-40% sucrose gradients. These were 
ultracentrifuged at 35,000 rpm (200,000g) for 45 min in SW41 ultraclear tubes in a 
Beckman L5-65 centrifuge. The bands were aspirated separately and pelleted from 
sucrose at 25,000 rpm (100,000 g) for VA hrs in SW28 ultraclear tubes in a Beckman 
L5-65 centrifuge. Pellets were resuspended in 2 ml of 100 mM Tris-HCl, pH 8.6 and 
loaded onto fresh 10-40% sucrose gradients, centrifuged at 35,000 rpm (200,000 g) for 45 
min as above, and bands aspirated. Bands were pelleted as above and resuspended in 200 
[il each of 100 mM Tris-HCl, pH 8.6, and stored at 4°C. 
3.2.3.2 Method 2 
All g forces quoted in this section were calculated using r maximum for the specific rotor 
used. 
Ten Flow bottles were seeded with BF-2 cells, incubated and inoculated as above. The 
lysed cells and virus were harvested at 9,000 rpm (15,000 g) for 30 min in the GSA rotor 
of the Sorvall RC-5B centrifuge. The supernatant was kept, and the pellets were 
resuspended, sonicated and centrifuged as above, after which the two supematants were 
pooled. The pooled supematants were loaded onto a 1.5 ml 60% sucrose cushion in 35 ml 
polypropylene Sorvall tubes and' centrifuged at 18,500rpm (45,000 g) for 45 min in the 
Sorvall RC-5B centrifuge. Pasteur pipettes were used to aspirate the cushion containing 
the virus. The suspension was dialysed overnight at 4°C against 100 mM Tris-HCl, pH 
8.6, to remove the sucrose, and concentrated to 2 ml in carboxymethyl cellulose (Aquacide 
II, Calbiochem), before being loaded onto two discontinuous 10-40% sucrose gradients 
and treated as decribed in Method 1. 
3.2.3.3 Method 3 
All g forces quoted in this section were calculated using r average for the specific rotor 
used. 
Ten Flow bottles were seeded with BF-2 cells, incubated and inoculated as above and the 
lysed cells and virus were harvested at 9,000 rpm (12,000 g) for 30 min in the GSA rotor 
in a Sorvall RC-5B centrifuge. The supernatant (SNl) was placed at 4°C while the pellet 
was resuspended in a small volume of SNl, This was subjected to three rapid freeze/thaw 
cycles using liquid nitrogen and a 37°C water bath, followed by ultrasonication for three 1 
min cycles, before being centrifuged at 8,000 rpm (6,500 g) for 15 min in the SS34 rotor 
in a Sorvall RC-5B centrifuge. This supernatant (SN2) was pooled with SNl and stored 
overnight (ON) at 4°C, while the pellet was discarded. The virus was pelleted from the 
pooled SN by centrifugation at 8,000 rpm (10,000 g) for 8 hrs in the GSA rotor in a 
SorvairRC-5B centrifuge and resuspended in 2 ml total volume of 100 mM Tris-HCl pH 
8.6. The suspension was equally divided and loaded onto two preformed discontinuous 
gradients and centrifuged at 35,000 rpm (150,000 g) 45 min in the SW41 rotor of the 
Beckman L5-65 ultracentrifuge. The gradients used were 15-60% sucrose (60 gm sucrose 
was dissolved in 100 ml of 100 mM Tris-HCl, pH 8.6, filter sterilised to make 60% 
sucrose solution and 45%, 30% and 15% were made from this by diluting the 60% 
solution in 100 mM Tris-HCl, pH 8.6; the gradients were poured in 2 ml steps using a 19 
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G needle and 2 ml syringe, with 60% solution on the bottom, and left to equilibrate at RT 
overnight). Resulting bands were harvested separately by aspiration with a 21 G needle 
and 2 ml syringe, diluted in 100 mM Tris-HCl, pH 8.6, until the concentration of sucrose 
was about 10%, then pelleted through a 5 ml cushion of 20% sucrose at 25,000 rpm 
(80,000 g) for Ihr in the SW28 rotor in a Beckman ultracentrifuge. Pellets were 
resuspended in 200 îl of 100 mM Tris-HCl, pH 8.6, and stored at 4"C in sterile 1.5 ml 
eppendorf tubes (ETs) (see Figure 3.1). 
To assess if the virus was free from any contaminating cellular material it was viewed by 
electron microscopy, and then analysed using polyacrylamide gel electrophoresis with 
sodium dodecyl sulfate (SDS-PAGE), and by western transfer with immunostaining. 
3.2.4 Electron Microscopy 
A small drop (10 |xl) of the virus preparation was negatively stained with an equal volume 
of 2% phosphotungstic acid (PTA). A collodion coated copper grid was placed on the 
droplet for 30 sec then removed to dry for 5 min, before being viewed under a Phillips 
201 transmission electron microscope and photographed. 
3.2.5 SDS-Page and Western Transfer 
Virus preparations were disrupted with 1/3 volume of 4x sample buffer (0.25 M Tris-HCl 
pH 6.8, 40% glycerol, 8% SDS, 20% p-mercaptoethanol) and 1 fxl of 1% w/v 
bromophenol blue (Sigma, USA) and boiled for 3 min. A 12% polyacrylamide separating 
gel and 4% stacking gel were used. Molecular weight standards (Biorad, USA) were 
included with each gel and running time was VA hr at a constant current of 30 mA. These 
conditions were similar to those described by Laemmli (1970). The gel was either stained 
with 0.2% w/v coomassie brilliant blue (CBB) or transferred immediately onto an 
Immobilon-P membrane (Millipore, Sydney, Australia) at a constant voltage of 90 V for 3 
hr. The membrane was air dried at RT and stored at 4°C overnight. 
3.2.6 Immunostaining 
The membrane was wetted in 100% methanol and rinsed in distilled water before free 
protein binding sites were blocked with 1% w/v gelatin in TS buffer (100 mM Tris-HCl 
pH 7.4, 0.15 M NaCl) for 30 min at RT. Rabbit antiserum diluted 1:200 in TS, 0.05% v/v 
Tween 20, 0.1%gelatin (BTS) was reacted for 120min, followed by swine anti-rabbit 
immunoglobulin conjugated to horse raddish peroxidase (Dako Corporation, Denmark ) 
diluted 1:250 in BTS for 120 min. Three 10 min washes in TS/0.05% v/v Tween 20 were 
conducted after each incubation. Binding of the conjugate was detected with the 
chromagen 4-chloro-l-naphthol (Biorad, USA). 
3.2.7 Production of Anti-BF-2 Cell Antibody 
Blue Gill Fry (BF-2) cells were grown in 25 cm' tissue culture flasks with growth 
medium (section 2.2) at 24°C until monolayers were confluent. They were then harvested 
using ATV (NaCl, KCl, NaHC03, 0.05% Trypsin, 0.1% glucose, EDTA) to lift the 
monolayer and centrifuged at 6500 rpm (3,000 g) for 2 min in the bench top (Sorvall 
microspin 24S) centrifuge. The pellet was washed twice with phosphate buffered saline, 
pH 7.2 (PBS) and resuspended in final volume of 1.5 ml PBS, before being ultrasonicated 
for three 1 min cycles in a Branson Sonifier Cell Disruptor - B15 (Branson Co, USA). 
The cell suspension (1.5 ml) was emulsified (aspirated in and out of a syringe with a 19 
G needle) with 1.5 ml of Freund's complete adjuvent (FCA) (Sigma, USA), and stored at 
4°C. A preliminary sample of blood was taken from a rabbit (30 ml). The BF-2 cell 
prepation was inoculated intramuscularly (0.75 ml total) at each of two sites in the hind 
legs and 0.8 ml was given subcutaneously 3 and 6 weeks later. Blood was collected 
fortnightly, left at least 2 hr at RT to clot and centrifuged at 2000 rpm (900 g) for 15 min 
in a bench top Centra-7 (lEC). The sera were tested in a gel diffusion test (see section 
2.3) against a BF-2 cell lysate and stored at -20°C. 
3.3 Results 
3.3.1 Growth of EHNV 
The rainbow trout isolate of EHNV (86:8774) did not produce CPE in the FHM cell line 
at 28°C. CPE occurred in both RTG and BF-2 cell lines, characterised by complete lysis 
of the BF-2 monolayer in 4 days, and the RTG monolayer in 6 days. Titrations of the 
resuhant supematants, harvested 7 days post infection, revealed a slightly greater TCID50 
in the supernatant of the BF-2 stock ie: 10^^ TCIDjo/ml for the rainbow trout isolate 
grown in BF-2 cells, and 10"' TCIDj^ml for the rainbow trout' isolate grown in RTG 
cells. 
BF-2 cells were used for all subsequent viral culture because of greater ease of handling 
in the cell culture laboratory and because it was desired to use cells antigenically 
heterologous to the species of fish for which immunological tests were being developed, 
namely the rainbow trout. 
3.3.2 Effect of temperature on the growth of EHNV 
a. Focal rounding started to appear after 20 hrs and scattered foci of CPE were present 
after 46 hrs at each of the three temperatures. After 70 hrs flasks at 20°C displayed 
disruption of half the monolayer by CPE (50% CPE), while flasks at 25°C displayed 90% 
CPE. At 75 hrs flasks at 15°C displayed 50% CPE, while CPE was complete in flasks at 
20°C and 25°C (Table 3.1). The results of subsequent titrations given in Table 3.2 reflect 
the development of CPE. 
b. Titrating two different rainbow trout isolates of EHNV at three temperatures showed 
distinct differences in the growth of EHNV. At 30°C neither isolate displayed CPE. At 
27°C isolate 1 showed no CPE, and isolate 2 had CPE with a TCID^o of lO'^/ml. At 20°C 
isolate 1 had a TCID50 of lO'-'Vml, and isolate 2 lO'-^/ml. 
c. Using a tube procedure to grow 5 rainbow trout isolates of EHNV at three temperatures 
also revealed that EHNV grows poorly, if at all, at temperatures greater than 25°C (Table 
3.3). 
3.3.3 Purification of EHNV. 
3.3.3.1 Method 1 
Two bands formed close to the bottom of the gradient, one diffuse band (TCID5o=10'°Vml) 
at about 30% sucrose, just above a slightly more discrete band (TCIDjo=10'7ml) at about 
35% sucrose. A substantial pellet also formed at the base of the gradient 
(TCID3o=10'7ml). The bands were much fainter after being run on a second gradient. 
Table 3.1: A time course study at three temperatures. The 
development of CPE over 75 hrs caused by growth of EHNV in 
BF-2 cells at 15, 20 and 25°C. At the temperatures below 25°C 
CPE was marginally slower at developing. 
Time (hrs) 15°C 
Presence of CPE 
20°C 25°C 
0 - - -
4 - - -
20 FR FR FR 
24 FR FR FR 
28 FR FR FR 
46 CPE CPE CPE 
49 CPE CPE CPE 
53 CPE CPE 50%CPE 
70 CPE 50%CPE 90%CPE 
75 50%CPE 100%CPE 100%CPE 
Key: FR = Focal rounding 
- = No CPE 
Table 3.2: Titration of total EHNV released from monolayer 
at three temperatures. EHNV was grown in BF-2 cells for 75 
hrs at 15, 20, and 25°C. The supematants were freeze/thawed and 
titrated in BF-2 cells at 24°C. The TCIDjo's being reported for 
each temperature at various time intervals over the period of 
growth reflected the marginally slower development of CPE at 
lower temperatures. 
Time (hrs) 15oC 
TCIDsc/ml 
20oC 25oC 







Table 3.3: Effect of temperature on the 
growth of EHNV. Five rainbow trout 
isolates of EHNV were grown in tube 
cultures of BF-2 cells at 20, 27, and 30°C. 
After 7 days it was apparent that the 
higher the temperature, the less likely it 
was for the isolates to produce CPE. 
Presence of CPE. 
Stock 
viruses 20°C 2TC 30°C 
1 + + -
2 + - -
3 + + + 
4 cont cont cont 
5 + - -
Key: + = CPE Present 
- = No CPE 
cont = Contaminated and no result. 
3.3.3.2 Method 2 
This method was unsuccessful. It was attempted four times; the dialysing suspension 
became contaminated with bacteria in the first, the dialysis bag burst in the second, and 
the two subsequent runs failed to produce bands on the gradient. The latter was presumed 
to be due to the failure of incubators, overheating of cultures and low yields of virus from 
the cells. 
3.3.3.3 Method 3 
This method was combined with more precise regulation of incubation temperatue during 
viral growth. The use of the 15-60% sucrose gradients resulted in the formation of two 
prominant bands when observed after ultracentrifugation (Figure 3.2). No light source was 
necessary as bands could be seen clearly with the naked eye. Band 1 (Bl) was a slightly 
slower sedimenting band just below the middle of the tube (38% sucrose), while Band 2 
(B2) was a more discrete band closer to the bottom of the tube (50% sucrose). The 
volume collected when each band was aspirated was about 1 - 4 ml. For every 10 Flow 
bottles (Surface area = 170 cm^ volume: 100 ml media), B l yielded 0.45 mg of protein 
with a TCID50 of lO'-'Vml (lO"*" TCID50 total virus), while B2 yielded 0.15 mg of protein 
with a TCID50 of lO'-^'/ml (10' ' ' TCIDjo total virus). This resulted from a starting 
concentration of 10'-^ TCIDs^/ml in the pooled supernatant (10"" TCID50 total virus) in a 
volume of 1 L. Method 3 is illustrated in Figure 3.1. 
An experiment was conducted where Method 1 and Method 3 were run simultaneously 
using cell cultures incubated at fhe same time and incubated identically. This resulted in 
very similar banding but Method 3 was chosen for further purification of EHNV due to 
Figure 3.2: Sucrose gradient purification of EHNV. An SW41 ultra clear tube 
containing a 15-60% sucrose gradient that has been centrifuged to yield purified EHNV 
bands 1 (upper) and 2 (lower). 
ease of procedure. 
3.3.4 Electron Microscopy 
To assess the purity of the recovered virus preparations from method 3, B1 and B2 were 
negatively stained and viewed under the electron microscope. B1 contained viral particles 
along with amorphous, extraneous material (Figure 3.3), while B2 contained many viral 
particles and was apparently free of any other material. Both enveloped and 
non-enveloped virions were observed in B2 (Figure 3.4). 
3.3.5 Gel Diffusion Tests 
Purified B2 was used as the antigen and no precipitation bands occurred for the prebleeds 
and first immune bleeds (4 weeks) of the sheep and rabbit. The second immune bleed (6 
weeks) produced precipitin bands from both the sheep and the rabbit. 
3.3.6 SDS-Page and Immunostaining of Western Transfers 
SDS-PAGE of Bl , B2, and control BF-2 cell lysate revealed approximately 8 major 
protein bands and 5 - 7 minor bands common to Bl and B2 in coomassie brilliant blue 
stained gels. However, Bl contained many extra bands which were common to the 
innumerable bands resolved in the samples from the control BF-2 cells (Figure 3.5). 
Immunostaining of western transfers of Bl, B2 and control BF-2 cell lysate with rabbit 
anti BF-2 immune serum also indicated that B2 was less contaminated with cell proteins 
than Bl . B2 contained only a small amount of cell protein, recognised as two bands by 
anti-BF-2 serum (Figure 3.6). Pre-immune serum from this rabbit failed to detect any 
Figure 3.3: Sucrose gradient purified EHNV (Bl). Electron micrograph of sucrose 
gradient purified EHNV, Band 1 (Magnification x 43 000). Arrows indicate virus. 
Figure 3.4: Sucrose gradient purified EHNV (B2). Electron micrograph of sucrose 
gradient purified EHNV, Band 2 (Magnification x 43 000). 
Figure 3.5: S D S - P A G E analysis of B F - 2 cell lysate and sucrose gradient purif ied 
E H N V . B F - 2 cell lysatc (lane 2), sucrosc gradient purif ied E H N V Band 2 (lane 3), and 
sucrose gradient purif ied E H N V Band 1 (lane 4); molecular mass markers (in kDa) (lane 
1) were run on an S D S - P A G E gel and stained with coomass ie brilliant blue. 
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Figure 3.6: Western blot analysis of BF-2 cell lysate and sucrose gradient purified 
EHNV. The lanes contain the same material as in Fig 3.5, the blot being exposed to 
rabbit-ant i-BF-2 immune serum and swine-anti-rabbit-HRP for the immunostaining 
procedure. 





antigens in Bl, B2 or the BF-2 cell lysate (data not shown). 
3.4 Discussion 
In order to assess the importance of incubation temperature on the growth of EHNV in 
vitro various experiments were undertaken. These demonstrated that growth of EHNV is 
dependent on temperature. EHNV tends to grow slightly slower at temperatures around 
15°C, very well between 20°C and 25°C, and poorly near 30°C. All virus production was 
subsequently undertaken at 22°C. Roberts and Dobos (1983) have demonstrated that 
infectious pancreatic necrosis virus of fish will replicate very well at 20°C, but will not 
replicate at 28"C. 
Only a limited amount of information is currently available on EHNV, the virus being first 
described in 1986 by Langdon, et al.. EHNV is believed to be a member of the 
Iridoviridae and is a relatively large (148-167nm), icosahedral virus. FV3 appears to be 
the iridovirus most closely related to EHNV, and is of a similar size and shape (Eaton et 
al., 1991). Unlike EHNV, FV3 has been extensively studied and purification protocols 
have been described by many authors (Vilagines and McAuslan, 1970; Tan and McAuslan, 
1971; Aubertin et al., 1973; Braunwald, 1979; and Aubertin, 1980.). In this study 
techniques previously used to purify FV3 were employed. Method 1 was successful in 
purifying EHNV and was a combination of methods used by Aubertin et al. (1973) and 
Aubertin et al. (1980). Much of the virus, however, moved straight through the gradient to 
form a pellet which reduced the yield of purified virus. It was assumed that the virus had 
clumped in the preceding high-speed centrifugation step. Hence, sonication of the viral 
suspension after the high speed pelleting step was introduced in an attempt to disperse the 
virus prior to gradient centrifugation. This was not beneficial as it appeared to damage 
virus particles so they would no longer band on the gradients. In view of the above, the 
high speed spin to pellet the viral bands after initial gradient centrifugation was thus 
replaced by diluting the bands, with 100 mM Tris-HCl pH 8.6, to less than 10% sucrose 
before re-loading on the second gradient. This appeared to be successful as subsequent 
bands were visibly more dense and the pellet was much reduced after the gradient was 
centrifuged. 
Method 2 was attempted in an effort to overcome the clumping thought to occur during 
the high speed spin (45,000 g for 45 min) to pellet the virus from the pooled supernatant. 
The 60% sucrose cushion should have decreased the impact of the pelleting virus on the 
bottom of the centrifuge tube and thus should have reduced clumping. Whether or not it 
did remains uncertain. The experiments were unsuccessful in purifying virus. It was 
discovered later that the incubation temperatures during viral growth were likely to have 
been 27°C instead of 24°C, due to an incubator failure, which would have inhibited viral 
growth and thus provided a reason for the failure of Method 2 to produce bands on the 
gradients. 
Method 3 was adapted from Method 1 to overcome the problems experienced with viral 
clumping. This method utilised a longer low speed spin (10,000 g for 8 hrs), instead of the 
high speed spin (45,000 g for 45 min). Virus was resuspended more easily following the 
low speed spin and no pellet formed in subsequent gradient steps. 
Two bands were obtained in the sucrose gradients; the lower band (B2) contained virions 
and few cellular proteins while the upper band (Bl) contained virions together with a 
considerable amount of cellular material as detected by SDS-PAGE, Western blotting with 
antiserum raised against BF-2 cells, and electron microscopy. 
It appears that EHNV is highly cell-associated because the physical procedures which we 
used to disrupt the cell did not fully release the virus, thus resulting in two bands. One 
band (B2) is almost pure virus and possibly associated with lipids making it more dense 
than the more highly cell associated virus (Bl) which settles higher on the gradient due to 
its association with more buoyant cell constituents. Sucrose gradients of 10-40% were 
replaced by 15-60% sucrose gradients. This yielded bands which were more discrete, 
better separated and thus easier to collect. This suggests that EHNV is denser than FV3 as 
it needs higher sucrose concentrations to achieve good separation of the viral bands. The 
second gradient step was also eliminated as it appeared to decrease the yield of purified 
virus rather than further purify the virus, thus suggesting that the virus is relatively 
fragile, or unable to cope with repeated handling. 
In conclusion, EHNV was grown at an optimal temperature of 22°C in BF-2 cells. Virus 
purification Method 3 was the most efficient method to be established in the available 
time, and was thus used for subsequent production of purified EHNV. 
The results of this work were published in the Journal of Virological Methods: Steiner, 
K.A., Whittington, R.J., Petersen, R.K., Homitzky, C., and Gamett, H. (1991) Purification 
of epizootic haematopoietic necrosis virus and its detection using ELISA. J. Virol. Meth. 
33: 199-209. 
Subsequent to this study, workers at the Australian Animal Heahh Laboratory, Geelong, 
Victoria, published a method for purification of EHNV (Eaton et al., 1991). This method 
involved growing virus in monolayers of BF-2 cells, which were harvested at 850 g in a 
benchtop centrifuge, washed once with PBS, and lysed using a Dounce homogeniser. 
Debris was sedimented in an Eppendorf centrifuge, the supernatant was layered onto a 
30-57% sucrose gradient and centrifuged at 150000 g for 2 hrs in a Beckman 
ultracentrifuge using an SW41 rotor. The viral band was removed, dialysed overnight, 
layered over a 25-56% potassium tartrate gradient and centrifuged at 175000 g overnight 
in a SW41 rotor. Gradient material was collected by fractionation. Both this method and 
that developed by the author appear suitable for purifying EHNV. 
4. Chapter 4 - Development of an Antigen Capture ELISA for the 
Detection of EHNV 
4.1 Introduction 
Labelled reagent immunoassays have come to play a major role in the modem diagnostic 
laboratory. These assays include fluorescent labels, gold labels, biotin labels, radioisotope 
labels and enzyme labels. A sensitive and simple type of enzyme linked immunosorbant 
assay (ELISA) was described by Engvall and Perlmann in 1972, whereby tubes were 
coated with antigen and incubated with antiserum before the addition of an enzyme 
labelled anti-immunoglobulin to enable quantitation of antibodies. The ELISA technique 
has proven to be an extremely versatile procedure since then, and it is now widely used 
for detecting and quantitating antigens and antibodies, as well as other substances such as 
hormones, lymphokines and some chemicals (Entwistle and Ridd, 1988; Layton, 1988; 
Harrison et al., 1989) in both plants and animals. 
According to Burgess (1988), the direct ELISA is the simplest format for this technique. 
Here the antigen is bound to a solid phase, is reacted with a labelled antibody, and 
visualised with a substrate. Other configurations include: the indirect ELISA, where a 
primary antibody is included between the antigen and a labelled antibody; the antigen 
capture ELISA, which uses an antibody bound to the solid phase to specifically capture 
the antigen, and followed with either the direct or indirect system; the antibody capture 
ELISA, where an anti-species antibody is bound to the solid phase to capture the test 
antibody, and the detector is a labelled antigen; and lastly, a competitive ELISA, in which 
two reagents are added simultaneously and compete for sites on the antibody or antigen. 
These are the basic configurations of the ELISA, but there are many variations of these 
formats in existence. 
The key feature of the assay is the fact that antibodies or antigens can be linked to an 
enzyme, with the complex retaining both its enzymatic and its immunological activity. 
This complex can offer considerable sensitivity in detection assays by combining the 
specificity of the antigen/antibody interaction with the amplification of the catalytic 
enzyme reactions. The most commonly used enzymes are horseradish peroxidase (HRP), 
alkaline phosphatase (AP), urease, p-galactosidase, and glucose oxidase (Heytman, 1988). 
The type of substrate used to visualise the reaction will depend on the enzyme. The more 
commonly used chromagens are 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid 
diammonium salt) (ABTS) , 3,3,5,5,-tetramethylbenzidine (TMB), 
ortho-phenylenediamine (OPD), 4-chloro-l-naphthol (4CN), and 3,3'-diaminobenzidine 
(DAB), for horseradish peroxidase, (with the substrate usually being HjOj) and para nitro 
phenyl phosphate (PNPP) and 5-bromo-4-chloro-3-indolyl phosphate / Nitro blue 
tetrazolium (BCIP/NBT) for alkaline phosphatase. 
Other advantages of the ELISA are its speed, the stability of the reagents, and the ease 
and safety of the procedure (Voller et al., 1979). 
A variety of immunological approaches is available for detecting and identifying viral 
antigens. It was decided to devetop an indirect antigen capture ELISA in this study as it 
is much quicker than virus isolation which is the current method for diagnosis of EHNV, 
it is also a sensitive and specific assay which is easily undertaken. It was hoped that the 
assay would be sufficiently sensitive to enable it to replace virus isolation as the method 
of choice for diagnosis of EHNV. The general format of an indirect antigen capture 
ELISA is: a specific antibody is immobilised on the solid phase to bind selectively with 
the antigen of interest in a test sample. Any contaminants are removed by washing. The 
bound antigen is then detected by another specific antibody which may or may not be 
enzyme labelled. If it is not, then a labelled antispecies antibody is required. Bound 
labelled antibodies are then demonstrated by adding a substrate of the enzyme which 
produces a coloured product. 
The performance of an indirect antigen capture ELISA is directly dependent on the quality 
of the capture and detector antibodies. Antibodies raised against EHNV need to be free of 
binding activity specific for contaminating host cell antigens for their successful use in an 
antigen capture ELISA. Consequently the antigen (EHNV) was purified (see Chapter 2) so 
that it could be used for the production of hyperimmune serum (antiserum) by the 
intentional immunisation of an animal with the specific immunogen (antigen) in order to 
obtain a supply of antibodies against that immunogen (Smith, 1988). This chapter will 
discuss the production of hyperimmune sera in sheep and rabbits against EHNV, and the 
use of these antisera in the development of an antigen capture ELISA for the detection of 
EHNV. 
4.2 Methods 
4.2.1 Production of Anti-EHNV Antibody. 
Sucrose gradient purified virus (B2), prepared as described in section 3.2.3.3, was 
suspended in 100 mM Tris-HCl pH 8.6, 0.15 M NaCl and emulsified in an equal volume 
of FCA. A sheep and a rabbit were chosen on the the basis of minimum reactivity against 
EHNV by Western blotting of prebleed serum and each vaccinated with the purified virus. 
This was administered subcutaneously in two doses three weeks apart. The sheep were 
given a total of 2 ml at each of four sites in each dose (380 img protein total), while the 
rabbit received 0.5 ml at three sites for dose 1 (143 îg protein) and 0.5 ml at four sites 
for dose 2 (190 ng protein). Protein concentrations were estimated using the Bradford 
method (Bradford, 1976). 
The sheep was bled from the jugular vein and the rabbit was bled from the marginal ear 
vein. Both animals were bled fortnightly. Blood was allowed to clot for 2 hrs at RT and 
serum was collected after centrifugation at 2000 rpm for 15 min. Serum was stored at 
-20°C and specificity was evaluated by gel diffusion precipitation and immunoblotting 
reactions using procedures described in sections 2.3 and 3.2.6 respectively. The sheep 
antiserum was detected with donkey-anti-sheep-HRP (Silenus, Melbourne, Australia). 
4.2.2 Production of Viral and Cell Antigens for Development of an ELISA 
A mature 170 mm forklength redfin perch, maintained in a 120 L closed circle filtration 
aquarium was injected intraperitoneally with 2x10'' TCID50 of EHNV, RT strain 86:8776, 
according to the method of Langdon (1989). The fish died 8 days after inoculation and 
organs (liver, kidney and spleen) were removed asepticaily, homogenised, passaged 3 
times in BF-2 cells at 22°C and the culture supematants pooled and titrated as described 
in section 2.5. 
The BF-2 cell lysate was prepared according to the procedure described in the first part of 
section 3.2.7 where cells were prepared for production of ant i-BF-2 cell antibody. 
4.2.3 Affinity purification of antisera from both the sheep and the rabbit 
To affinity purify some of the antisera, a protein A column was used. Protein A Sepharose 
CL-4B (Pharmacia) (1.5 g) was swollen in 20 ml of Tris-saline starting buffer (25 mM 
Tris-HCl, pH 7.2, 0.15 M NaCl, 0.01% sodium azide), for 15-20 min. The swollen gel 
was poured smoothly into an emptied PD-10 column (Pharmacia) and 150 ml of starting 
buffer was run through the column to pack the gel. Serum (1 ml) was centrifuged at 6000 
rpm (3000 g) for 10 min in a benchtop micro-centrifuge. The supernatant was mixed with 
an equal volume of starting buffer and the 2 ml of diluted serum was then loaded onto the 
column with a transfer pipette, and washed through with 25 ml of starting buffer at a flow 
rate of 10 ml/hr. IgG was eluted with 30 ml of elution buffer (0.1 M glycine-HCl pH 
3.0, 0.15 M NaCl), at a flow rate of 30 ml/hr. Fractions of 2.5 ml were collected using an 
LKB fraction collector. A volume of 35 jxl of 2 M Tris-HCl, pH 10, was added 
immediately to each fraction to neutralise it, and the fractions were then pooled. Pooled 
fractions were dialysed over night against starting buffer, and concentrated by dialysis 
against Aquacide II (Calbiochem) to a final volume of 2 ml. A sample of whole serum 
and affinity purified immunoglobulin were run on an SDS-PAGE gel to confirm isolation 
of immunoglobulin. Purified immunoglobulins were stored at -20°C. 
4.2.4 Optimization of Reagents and ELISA Configuration. 
The standard ELISA procedure used is described in Appendix A. In order to format the 
ELISA for optimum sensitivity and specificity, the following were evaluated: (1) the effect 
of different proteinaceous blocking agents, (2) adsorbing the sheep-anti-B2 serum to 
reduce reactivity with the host cell antigens, (3) titration of all reagents, (4) assaying with 
and without a capture antibody, (5) affinity purification of rabbit-anti-B2 and 
sheep-anti-B2 sera, and their use as capture and detector antibodies, (6) effect of different 
types of conjugate, (7) effect of different types of substrate, and (8) a competitive ELISA 
to reduce cellular reactivities and adsorption with Mycobacterium to reduce background. 
1. Three blocking agents were compared in the standard ELISA and these were: 1% w/v 
ovalbumin (Sigma, USA) in PBS/0.05% Tween 20 (PBST), 1% w/v gelatin (Government 
stores, Sydney, Australia) in PBST, 1% w/v skim milk (Allowrie foods, Sydney, 
Australia) in PBST, and PBST alone. 
2. The sheep-anti-B2 serum was diluted 1:200 in PBST/0.1% ovalbumin (PBSTO) and 
1.9 ml was adsorbed with 100 \x\ of one of the following: MEM, PCS, BF-2 cell lysate 
(produced as described in the first part of section 3.2.7), BF-2 cell lysate + MEM (50 fxl 
of each), and BF-2 cell lysate + PCS (50 of each). These solutions were left at room 
temperature for l - lVi hrs, then used in the ELISA as the second antibody against a variety 
of antigens: EHNV, BF-2 cell lysate, and MEM, as per the standard ELISA method (see 
appendix A). 
3. All reagents were titrated. Whole rabbit-anti-B2 serum was diluted in doubling 
dilutions from 1:100, 1:200 1:51200 in borate coating buffer (BCB) (100 mM boric 
acid, 26 mM disodium tetraborate, 75 mM NaCl) for titration of capture antibody, with the 
rest of the ELISA being as per Appendix A. The second antibody and the conjugate were 
also titrated using this method, however, the diluent for these antibodies was PBSTO. 
4.a. The effect of reversing the capture and detection antibodies was assessed. 
Sheep--anti-B2 serum diluted 1:200 in BCB was coated to a plate overnight at 4°C. 
Antigen (prepared as in section 4.2.2) was used neat. Second antibody used was 
rabbit-anti-B2 serum at 1:200 and affinity purified rabbit-anti-B2 immunoglobulin (as 
prepared in section 4.2.3) at 1:800 in PBSTO. The conjugate was goat-anti-rabbit-HRP 
(Kirkegaard and Perry Laboratories Inc, Maryland, USA) diluted 1:250 in PBSTO. 
b) The affinity purified capture immunoglobulin was assessed by comparing affinity 
purified immunoglobulin (1:800) and whole rabbit sera (1:200, 1:800) against neat antigen 
(prepared in section 4.2.2) in an ELISA. These sera were diluted in BCB and used as 
capture antibody, with remainder of ELISA undertaken as described in Appendix A. 
c) The use of a capture antibody was assessed by using the antigen prepared in section 
4.2.2, neat and diluted 1:2, 1:4, and 1:8 in BCB. This was coated to a plate overnight at 
4°C with no capture antibody and the remainder of ELISA undertaken as described in 
Appendix A. 
5. Effect of different conjugates on the sensitivity of the ELISA was analysed using the 
standard method for the ELISA' outlined in Appendix A the following conjugates were 
compared: 
i. A polyclonal conjugate (rabbit—anti—sheep (IgG)—HRP, Kirkegaard and Perry 
Laboratories Inc, Maryland, USA) and a monoclonal conjugate (mouse-anti-sheep 
(IgG)-HRP (Australian Monoclonal Developments, supplied by Silenus Laboratories, 
Melbourne, Australia) which was referred to as AMD Bi2 HRP). 
ii. AMD Bi2 HRP and an alkaline phosphatase conjugated monoclonal mouse-anti-sheep 
(IgG) (Australian Monoclonal Development, supplied by Silenus Laboratories, Melbourne, 
Australia) which was referred to as AMD Bi2 AP. 
iii. AMD Bi2 HRP and monoclonal mouse-anti-ruminant (IgG)-HRP conjugate (Arimab 
HRP constructed at the Immunology and Microbiology Laboratories, EMAI, Sydney, 
Australia) along with AMD Bi2 AP and Arimab AP (also constructed at the Immunology 
and Microbiology Laboratories, EMAI, Sydney, Australia). When using AP conjugates 
PNPP was the substrate of choice. A tablet PNPP was added to 10 ml of diethanolamine 
buffer (9.7 ml diethanolamine/1 ml 100 mM MgCySO ml water, pH 9.8, and made to 100 
ml). PNPP was allowed to react for 30 min in the dark, before the reaction was stopped 
with 3 M NaOH, and reading at 405 nm. 
6. Effect of different substrates on the sensitivity of the ELISA was analysed. Substrates 
other than ABTS, that were evaluated in the standard ELISA were TMB and OPD. When 
using the TMB substrate the plate was placed in the dark for 10 min, the enzyme reaction 
was stopped with an equal volume of 1 M H^SO ,̂ and read at 450 nm, while when using 
OPD the plate was shaken for 15 min in the dark, the reaction stopped with Vi volume of 
2.5 M H2SO4, and read at 495 nm. 
7. Attempts were made to reduce background reactions. In order to reduce the 
backgrounds with control cell culture lysates or control fish tissues when using sheep-
anti-B2 serum as the detecting antibody, attempts were made to block BF-2 cell or 
possible rainbow trout tissue reactivity by using rabbit-anti-BF-2 cell and rabbit-anti-
RTG cell sera to compete for cell or tissue binding sites and adsorption with 
Mycobacterium was used to reduce any activity with rainbow trout tissues. 
4.3 Results 
4.3.1 Production and Assessment of Anti-viral Antisera 
The sera from three sheep and two rabbits were prescreened using SDS-PAGE, western 
transfer and immunostaining methods described in sections 3.2.5 and 3.2.6 for pre-existing 
antibodies against Bl, B2 and BF-2 cell lysate. Both sera were added at 1:200 in BTS; 
For detection of sheep sera donkey-anti-sheep(IgG)-HRP (Silenus Laboratories, 
Melbourne, Australia) was used at 1:400 in BTS. For detection of rabbit sera swine-anti-
rabbit(IgG)-HRP (Dako Corporation, Denmark) was used at 1:250 in BTS. Faint bands 
against these antigens were detected in each sheep (Figure 4.2), but none were detected in 
the rabbits (western blot not shown). The sheep with least reactivity (used in Figure 4.2) 
and a rabbit were immunised with B2. Gel diffusion tests as described in section 2.3 
showed sera to be positive when reacted against B2 and negative against BF-2 cell lysate 
(preparation of lysate is described in section 3.2.7) five weeks after the first dose of 
vaccine. The sheep and rabbit sera were further tested for anti-B2 antibodies using 
immunoblotting. Very distinctive'bands were recognised in the lanes containing samples of 
virus from Bl and B2, using both the sheep and rabbit anti-B2 sera (Figures 4.1 and 4.2). 
Figure 4.1: Western blot analysis of BF-2 cell lysate and sucrose gradient purified 
EHNV. Molecular mass markers (in kDa) in lane 1, BF-2 cell lysate in lane 2, sucrose 
gradient purified EHNV B2 in lane 3, and sucrose gradient purified EHNV HI in lane 4 
were run on an SDS-PAGE gel and transferred to an immobilon membrane. They were 
reacted with rabbit-anti-B2 serum and swine-anti-rabbit-HRP, and lane 2 shows that 
there was almost no reaction with the BF-2 cell lysate while many bands were revealed 
for both the B2 and B1 virus. 
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Figure 4.2: Western blot analysis of BF-2 cell lysate and sucrose gradient purified 
EHNV. Molecular mass markers (in kDa) in lane 1, BF-2 cell lysate in lane 2, sucrose 
gradient purified EHNV B2 in lane 3, and sucrose gradient purified EHNV B1 in lane 4 
and these were repeated respectively in lanes 5-8. These were run on an SDS-PAGE gel 
and transferred to an immobilon membrane. Sheep-anti-B2 serum (prebleed, lanes 2-4; 
immune bleeds, lanes 6-8) was reacted with the blot and donkey-anti-sheep-HRP was 
used to detect any reaction. Lanes 2-4 revealed that there were pre-existing antibodies in 
the sheep sera and lanes 6-8 show that although very strong bands appeared for the B1 
and B2 virus there was also a reaction with the BF-2 cell lysate. 
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Faint bands were also recognised in BF-2 cell lysate by sheep anti-B2 serum but not by 
the rabbit-anti-B2 serum. This accounts for the different protein profiles of EHNV 
recognised by the sheep and rabbit-anti-B2 serum. These results suggested that adsorption 
of the sheep antisera may be required to achieve optimal specificity in the ELISA. 
43,2 Antigens for Evaluation of the ELISA 
The pooled virus containing culture supematants had a TCID50 of 10''7ml. BF-2 cell 
lysate, v^ith a protein concentration between 1-1.5 mg/ml was chosen empiracally and 
used as a control to indicate background reactivity against cell antigens. 
4.3.3 Optimisation of Reagents and ELISA Configuration 
4.3.3.1 Comparison of blocking agents 
Ovalbumin, gelatin, and skim milk were assessed as blocking agents. The antigen was 
added at the following dilutions in PBSTO: 1:1, 1:10, 1:20, 1:40, 1:80, 1:100, 1:200, 
1:400, 1:800, 1:1000, 1:10000, with BF-2 cell lysate at 1 mg/ml being used as a control. 
The remainder of the ELISA was carried out according to the standard method (Appendix 
A). 
It was found to be advantageous to use a blocking agent, as when none was used the 
background optical density increased by about 25%, as is indicated in the BF-2 cell 
controls in Table 4.7. However, there was no difference in the efficiency of the blocking 
agents (Table 4.7). Ovalbumin was used in all further experiments. 
4.3.3.2 Adsorption of sheep antisera 
Adsorption of the sheep anti-B2 sera with BF-2 cell lysate decreased the background 
reaction against BF-2 cell antigens by about 77%, that is the OD was reduced from 0.69 
to 0.16 (Table 4.1). Sheep-anti-B2 serum was also adsorbed with growth medium 
components (PCS and MEM), but adsorption with these components did not effect the 
ELISA OD (Table 4.1). In all subsequent experiments the sheep-anti-B2 serum was 
adsorbed with BF-2 cell lysate, but it was considered unnecessary to adsorb with growth 
medium components. 
4.3.3.3 Titration of all reagents 
For all preliminary experiments, both capture and second antibody were diluted 1:200, and 
conjugate 1:500 in BCB and PBSTO respectively. Titration of reagents did not 
significantly increase the sensitivity of the ELISA, but did enable the amount of serum 
being used in each assay to be decreased. The optimal dilutions were assessed to be 1:800 
for rabbit-anti-B2 serum as capture antibody and 1:400 for sheep-anti-B2 serum as 
second antibody. The dilution of AMD Bi2 HRP conjugate (1:500) was found to be 
optimal. 
4.3.3.4 Capture antibody 
a. Both sheep anti-B2 serum and rabbit anti-B2 serum were tested as capture antibodies 
with the other species antiserum as the second antibody. The results demonstrated that the 
rabbit antiserum was by far the more competent capture antibody (Table 4.2 and 4.3). 
With rabbit-anti-B2 serum as' capture antibody the optical densities increased with 
increasing capture antibody dilutions past 1:400 indicating a prozone effect. Optical 
Table 4.1: Effect of adsorption of sheep-anti-B2 serum. OD 
obtained in ELISA where sheep-anti-B2 serum with was adsorbed 
with a range of preparations before use. Three different 
preparations were used as antigen to determine background OD. 
Sheep-anti-B2 serum adsorbed with: 




Virus 0.92 0.56 0.53 1 .02 1.01 0.86 
BE Cells 0.69 0.52 0.45 0 .16 0.2 0.23 
Media 0.08 0.08 0.07 0 .07 0.08 0.08 
Table 4.2: Influence of dilution of rabbit-anti-B2 serum as 
capture antibody. OD obtained in ELISA where 5 dilutions of 
rabbit-anti-B2 serum were used as capture antibody with 4 
dilutions of sheep-anti-B2 serum as second antibody (Ab). 
Virus and BF-2 cell lysate were the antigens and both were 
bound to capture antibody. Capture antibody dilution for BF-2 










1:800 1:1600 Cells 
1:100 0.74 0.99 0.98 1.12 1.48 0.23 
1:200 0.73 0.98 1.16 1.06 1.36 0.21 
1:400 0.77 0.92 1.08 1.11 1.49 0.17 
1:800 0.6 0.66 0.93 1.0 0.98 0.13 
Table 4.3: Influence of dilution of sheep-anti-B2 serum as 
capture antibody. OD obtained in ELISA where sheep-anti-B2 
serum was used at 5 dilutions as capture antibody with 4 
dilutions of rabbit-anti-B2 serum as second antibody (Ab). 
Virus and BF-2 cell lysate were used as antigens and both were 
bound to the capture antibody. The dilution of the capture 










1:800 1:1600 Cells 
1:100 0.89 0.48 0.54 0.57 0.7 0.52 
1:200 0.34 0.38 0.37 0.5 0.41 0.45 
1:400 0.31 0.36 0.34 0.4 0.36 0.72 
1:800 0.51 0.29 0.29 0.33 0.32 0.33 
densities remained stable with increasing second antibody dilutions to 1:400, but at 1:800 
the optical densities started to fall. When the sheep-anti-B2 serum was used as capture 
antibody the optical densities were not only consistantly low, but the cell background level 
was also at least double the background levels obtained when rabbit-anti-B2 serum was 
used as capture antibody. 
b. Affinity purification of rabbit anti-B2 serum to produce the immunoglobulin fraction 
resulted in a vast improvement in the sensitivity of the ELISA. When affinity purified 
rabbit-anti-B2 immunoglobulins were used as capture antibody the virus could be 
detected at dilutions of 1:10 and 1:100, whereas previously it could only be detected in 
neat culture supernatant, ie: at a TCID50 of 10^ (Table 4.4). 
Affinity purification of sheep-anti-B2 serum decreased the activity of the sheep 
immunoglobulins as second antibody; adsorption with BF-2 cell lysate did not result in 
any improvement (Table 4.5). In all further experiments affinity purified rabbit-anti-B2 
immunoglobulin was used as capture antibody and the adsorbed sheep-anti-B2 serum was 
used as second antibody. 
c. A capture antibody increased the optical density and the sensitivity of the ELISA (Table 
4.6). Rabbit-anti-B2 serum enabled detection of antigen at a dilution of the neat 
preparation of 1:20, while affinity purified rabbit-anti-B2 immunoglobulin enabled 
detection of antigen at a 1:200-1:400 dilution of the preparation. The background reaction 
was about 25% greater where there was no capture antibody. 
Table 4.4: Effect of dilution of affinity purified rabbit-
anti-B2 serum as capture antibody. OD obtained in ELISA for 10 
dilutions of affinity purified rabbit-anti-B2 as capture 
antibody against 3 viral Ag dilutions. Cell OD = 0.2. Adsorbed 
sheep-anti-B2 serum was second antibody and mouse-anti-sheep-
HRP was the conjugate. 
Dilution of 
Capture antibody NEAT 
Viral Ag dilution 
1:10 1:100 
1:200 2.89 2.66 0.49 
1:400 3.15 2.74 0.49 
1:800 2.73 0.81 0.29 
1:1600 2.84 1.38 0.44 
1:3200 2.83 1.09 0.26 
1:6400 2.81 0.52 0.12 
1:12800 2.75 0.31 0.1 
1:25600 2.24 0.21 0.1 
1:51200 2.52 0.33 0.08 
1:102400 1.32 0.16 0.08 
Table 4.5: Effect of adsorbed and non-adsorbed affinity 
purified sheep-anti-B2 serum at 2 dilutions as capture 
antibody. OD obtained in ELISA for affinity purified sheep-
anti-B2 serum, both adsorbed and non-adsorbed with BF-2 cell 
lysate, as capture antibody. Affinity purified rabbit-anti-B2 
serum was used as second antibody at 10 dilutions. Cell OD 
were 0.16 for adsorbed sheep-anti-B2 serum, and 0.31 for non-









Neat 1 :10 
1:100 1. 63 0. 26 1 .4 0. 28 
1:200 1. 16 0. 22 1. ,05 0. 23 
1:400 0. 69 0. 19 0. ,58 0. 16 
1:800 0. 51 0. 16 0. ,39 0. 14 
1:1600 0 .3 0. 13 0. ,29 0. 12 
1:3200 0. 16 0 .1 0. ,17 0. 13 
1:6400 0. 14 0 .1 0. ,14 0. 11 
1:12800 0. 13 0. 13 0, ,13 0. 09 
1:25600 0. 11 0. 13 0. ,12 0. 11 
1:51200 0. 11 0 .1 0. ,12 0 .1 
Table 4.6: Comparison of OD for viral antigen coated directly 
to the plate with the OD when a capture antibody is coated 
directly to the plate. CD obtained in ELISA when virus was 
coated directly to the plate, as compared to whole 
rabbit-anti-B2 serum (R*B2) as capture antibody or affinity 
purified R*B2 as capture antibody (Ab). Viral antigen was used 
at 11 dilutions and the second antibody was adsorbed sheep-
anti-B2 serum. 
Viral Ag 
dilution No capture Ab 
Capture Ab 
R*B2 Aff Pur R*B2 
1:1 0.71 2.92 3.1 
1:10 0.2 0.77 3 
1:20 0.38 0.5 2.85 
1:40 0.22 0.28 2.46 
1:80 0.21 0.21 1.78 
1:100 0.17 0.19 1.54 
1:200 0.15 0.18 0.84 
1:400 0.14 0.14 0.47 
1:800 0.11 0.11 0.27 
1:1000 0.11 0.1 0.28 
1:10000 0.09 0.11 0.13 
CELLS 0.42 0.33 0.34 
Table 4.7: Comparison of proteinaceous blocking agents. OD 
obtained in ELISA when three proteinaceous blocking agents 
were compared. BF-2 cell lysate was used as control antigen 
and 11 dilutions of viral antigen were also used. Affinity 
purified rabbit-anti-B2 serum was capture antibody and 
adsorbed sheep-anti-B2 serum was second antibody. 
Viral Ag 
dilution 
Ovalbumin Gelatin Skimmilk No block 
1:1 2 .99 2 .8 2 .9 2. .76 
1:10 2, .83 2. 76 2. ,94 2. .81 
1:20 2. .47 2. 76 2. ,76 2. .78 
1:40 2, .29 2. 34 2 .2 2, .39 
1:80 1, .33 1. 62 1. ,43 1. .41 
1:100 1, .01 0. 97 1. ,15 1. .03 
1:200 0, .59 0. 76 0. ,61 0, .64 
1:400 0, .41 0. 43 0. ,42 0, .35 
1:800 0, .22 0 .3 0. ,28 0, .24 
1:1000 0. .25 0. 25 0, ,25 0, .21 
1:10000 0. .11 0. 14 0. ,13 0, .12 
Cells 0 .3 0. 31 0. ,33 0. .41 
4.3.3.5 Comparison of Conjugates 
i) Firstly, the standard ELISA (Appendix A) was used with neat viral antigen, and a 
polyclonal conjugate, rabbit-anti-sheep (IgG) -HRP (Kirkegaard and Perry Laboratories 
Inc, USA) was compared to a monoclonal conjugate, AMD Bi2 HRP, at five dilutions, 
1:250, 1:500, 1:1000, 1:2000 and 1:4000, for effect on assay results. The use of the 
polyclonal conjugate resulted in an extremely high background optical density of 1.51 in 
wells where BF-2 cell lysate at 1 mg/ml was a background control, and thus very low 
signal/noise (S/N) ratios (optical density of viral antigen/optical density of BF-2 cell 
lysate). At a conjugate dilution of 1:500, which appeared to be the optimal dilution, the 
monoclonal conjugate had a S/N ratio about five times greater than that of the polyclonal 
(Table 4.8 and Figure 4.3). Control wells not containing viral antigen gave high OD (0.4-
0.5) suggesting a cross reaction of the polyclonal HRP conjugate to bound capture 
antibodies. 
ii) The second comparison made was between the types of enzymes conjugated to the 
mouse anti-sheep monoclonal antibodies, ie: HRP and AP conjugated to the AMD-Bi2 
antibody. Very little difference in sensitivity was found between the two enzymes for 
higher dilutions of the viral antigen, but from a neat to 1:80 viral antigen dilution the AP 
enzyme had a higher S/N ratio (OD of viral antigen/OD of BF-2 cell lysate)(Figure 4.4). 
Optical densities using AP conjugate started to drop at an antigen dilution of 1:10, 
whereas the optical densities achieved using the HRP conjugate only had a downward 
trend, suggesting that the AP conjugate gives a better result at higher concentrations of 
virus, but as the amount of virus decreases there is little difference between the two 
conjugates. 
Table 4.8: Comparison of OD for a polyclonal and a monoclonal 
conjugate used in the antigen capture ELISA. OD obtained in 
ELISA and ratio of OD (S/N) for 5 dilutions of a polyclonal 
COjugate (KPL) and 5 dilutions of a monoclonal conjugate 
(AMD). Cell OD for KPL was 1.51, and 0.22 for AMD. Rabbit-
anti-B2 serum was capture antibody and adsorbed sheep-anti-B2 









1:250 2.22 2.22 1.93 10.09 
1:500 1.62 2.04 1.41 9.27 
1:1000 0.78 1.45 0.68 6.59 
1:2000 0.39 0.7 0.34 3.18 
1:4000 0.32 0.32 0.28 1.45 
Figure 43: Comparison of assay sensitivity using polyclonal and monoclonal 
conjugates. The ELISA plate was coated with rabbit—anti—B2 serum, viral antigen was 
used neat and adsorbed sheep-anti-B2 was the detecting antibody. The conjugates were 
added at 5 dilutions, 1:250, 1:500, 1:1000, 1:2000 and 1:4000. S/N (OD of viral 
antigen/OD of BF-2 cell lysate) ratio obtained in the ELISA between KPL (polyclonal 
donkey-anti-sheep-HRP conjugate) and A M D (monoclonal mouse-anti-sheep-HRP 
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Conjugate Dilution 
1 : 4 0 0 0 
KPL AMD 
Figure 4.4: Comparison of corrugated enzymes. S/N (OD of viral antigen/OD of BF-2 
cell lysate) ratio obtained in the ELISA comparing AMD Bi2 AP and AMD Bi2 HRP 
conjugates is demonstrated. The ELISA was carried out as described in Appendix A with 
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Viral Antigen Dilution 
AMD Bi2 AP AMD Bi2 HRP 
iii) The third comparison made was between monoclonal antibodies from different sources 
against sheep immunoglobulin. There was very little difference between Arimab-AP and 
AMD Bi2 AP. At higher antigen concentrations AMD Bi2 A? had slightly higher S/N 
ratios, but as the concentration of antigen decreased, the conjugates became almost 
indistinguishable, and both ceased to detect the virus at antigen dilutions greater than 
1:400 (Figure 4.5). Again similar trends were found when AMD Bi2 HRP and 
Arimab-HRP were compared (Figure 4.6). Conjugate AMD Bi2 HRP was chosen for all 
further experiments because it was in use in the laboratory in other assays and a regular 
supply and turnover of the reagent could be guaranteed. 
4.3.3.6 Comparison of Substrates 
At high concentrations of antigen, ABTS was by far the most sensitive chromagen, ie: it 
had a S/N ratio almost twice that of OPD and TMB (Table 4.9). However, as the antigen 
concentration decreased, the S/N ratios of the three chromagens showed little variation 
(Figure 4.7) although the S/N ratio for OPD remained greater than 2 up to a viral antigen 
dilution of 1:1000 (Table 4.9). 
4.3.3.7 Rapid ELISA 
A method for a rapid ELISA was also attempted. The plate was coated with affinity 
purified rabbit-anti-B2, diluted 1:800 in BCB and left for 2 hrs at RT. Two different 
virus positive cell culture stocks of EHNV from two isolations of wild virus were added in 
duplicate, along with MEM as a negative control, and left for 30 min. The sheep-anti-B2 
antisera was added at 1:400 in PBSTO and left for 15 min, before the conjugate, AMD 
Bi2 HRP was added at 1:500 for 15 min. The plate was washed three times in distilled 
Table 4.9: Comparison of OD of substrates used in the antigen 
capture ELISA. OD and ratio (S/N) obtained in ELISA for 3 
substrates using a HRP conjugated antispecies Ab at 11 viral 
antigen dilutions. Affinity purified rabbit-anti-B2 serum was 
capture antibody and adsorbed sheep-anti-B2 serum was second 






N 2.88 2.92 3.32 
1:10 2.85 2.7 3.15 
1:20 2.77 2.52 2.8 
1:40 2.7 2.16 2.81 
1:80 2.2 1.98 2.97 
1:100 1.91 1.91 2.77 
1:200 1.03 2.21 2.47 
1:400 0.63 2.4 1.54 
1:800 0.35 1.6 0.76 
1:1000 0.31 1.21 0.8 
1:10000 0.17 0.46 0.37 





N 15.16 3.60 10.06 
1:10 15.00 3.33 9.55 
1:20 14.58 3.11 8.48 
1:40 14.21 2.67 8.52 
1:80 11.58 2.44 9.00 
1:100 10.05 2.36 8.39 
1:200 5.42 2.73 7.48 
1:400 3.32 2.96 4.67 
1:800 1.84 1.98 2.30 
1:1000 1.63 1.49 2.42 
1:10000 o;89 0.57 1.12 
Figure 4.5: Comparison of coi\jugates. S/N (OD of viral antigen/OD of BF-2 cell 
lysatc) ratio obtained in the ELISA comparing ARIMAB AP and ARIMAB HRP 
conjugates is demonstrated. The ELISA was carried out as described in Appendix A with 
11 dilutions of the viral antigen and conjugates at 1:500. 
1:100 1:200 1:400 1:800 1:1000 1:10000 
Viral antigen dilution 
ARIMAB AP AMDBi2 AP 
Figure 4.6: Comparison of corrugates. S/N (OD of viral antigen/OD of B F - 2 cell 
lysate) ratio obtained in the ELISA comparing ARIMAB HRP and AMD Bi2 HRP 
conjugates is demonstrated. The ELISA was carried out as described in Appendix A with 
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1:8ÖÖ 1:1000 1:10000 
ARIMAB HRP AMD Bi2 HRP 
Figure 4.7: Comparison of substrates. S/N (OD of viral antigen/OD of BF-2 cell lysate) 
ratio obtained in the ELISA comparing ABTS, TMB and OPD substrates. The ELISA was 
carried out as descri&ed in Appendix A with 11 dilutions of the viral antigen. 
1:100 1:200 1:400 1:800 1:1000 1:10000 
Viral Antigen Dilution 
ABTS — ^ TMB OPD 
water with 0.05% Tween 20 between each of the above steps. ABTS was added and the 
reaction allowed to proceed for 20 min before reading at 405 nm. 
This experiment showed that it was possible to complete the EHNV antigen capture 
ELISA in about 3l/2 hrs, and still expect high optical densities. For instance, the two field 
samples shown to be positive for virus by isolation had optical densities of 2.87 and 2.63, 
while the negative control (MEM) had an optical density of 0.23. 
4.3.3.8 Reducing background reactions 
a. A plate was coated with affinity purified rabbit-anti-B2 at 1:800 in BCB and left 
overnight at 4°C, blocked for 30 min with 1% ovalbumin in PBST, and the following 
antigens added: 1. viral antigen as prepared in section 4.2.2 and diluted 1:100, 2. BF-2 
cell lysate at 0.84 mg/ml, 3. homogenate of organs from a rainbow trout free of the virus. 
This was left for 90 min. The sheep-anti-B2 (SxB2) serum was diluted for a final dilution 
of 1:400 in PBSTO and added with the following combinations: 1. SxB2, 2. SxB2 + 
rabbit-anti-BF-2 cell lysate serum (RxBF-2) 1:200, 3. SxB2 + RxBF-2 1:400, 4. SxB2 
+ RxBF-2 1:800, and 5. SxB2 + BF-2 cell lysate. All dilutions were in PBSTO. This was 
left for 90 min, and the rest of the ELISA was undertaken as described in Appendix A. 
Adsorbing the sheep-anti-B2 serum with BF-2 cell lysate decreased the resulting optical 
density of the ELISA when the BF-2 cell lysate was the antigen ie: the resultant OD was 
0.41 for sheep-anti-B2 serum alone compared to 0.17 when the serum was adsorbed with 
BF-2 cell lysate (Table 4.10). When rabbit-anti-BF-2 serum was present there appeared 
to be an increased optical density for virus positive samples, and a marginally reduced 
Table 4.10: Attempts to reduce background OD for antigen 
capture ELISA when testing tissue homogenates. CD obtained in 
ELISA when the second antibody is absorbed with a range of 
agents and when a range of agents are used as a blocking step 
in the antigen capture ELISA. Antigens used were a viral 
positive culture supernatant, BF-2 cell lysate and virus free 
tissue homogenate from rainbow trout. Affinity purifed rabbit-
anti-B2 serum was capture antibody and mouse-anti-sheep-HRP 
was the conjugate. 






S*B2(1:400) 0.89 0.41 0.3 
+R*BF-2 1:200 1.23 0.33 0.34 
+R*BF-2 1:400 1.16 0.37 0.32 
+R*BF-2 1:800 1.01 0.33 0.29 
+BF-2 Cell 0.78 0.17 0.29 
lysate 
Block 
R*BF-2 1:100 1.06 0.44 0.37 
R*BF-2 1:200 1.06 0.47 0.34 
R*BF-2 1:400 0.74 0.47 0.32 
R*BF-2 + R*RTG 1 0.57 0.39 
1:100 
R*BF-2 + R*RTG 0.9 0.53 0.4 
1:200 
R*BF-2 + R*RTG 0.86 0.5 0.38 
1:400 
R*RTG 1:100 1.14 0.61 0.38 
R*RTG 1:200 1.14 0.54 0.36 
R*RTG 1:400 1.04 0.6 0.34 
No block 0.83 0.57 0.26 
2nd Ab 0.88 0.31 0.27 
Adsorbed 
KEY 
R*BF-2 = rabbit~anti-BF-2 serum 
R*RTG = rabbit-anti-rainbow trout gonad serum 
S*B2 = sheep-anti-B2 serum 
optical density of wells containing BF-2 antigen (Table 4.10). There was no effect on the 
OD of rainbow trout tissue homogenates. 
b. A plate was coated and blocked as described in 4.3.3.8a. above. Antigens were added as 
in 4.3.3.8a. above. All further dilutions were in PBSTO. The rabbit-anti-cell sera 
(RxBF-2 and rabbit-anti-RTG sera (RxRTG)) were added in the following combinations: 
1. RxBF-2 at 1:100, 1:200, and 1:400, 2. RxBF-2 + RxRTG with both sera at 1:100, 
1:200, and 1:400 final dilutions. 3. RxRTG at 1:100, 1:200, and 1:400, 4. no anti-cell 
sera, and 5. no anti-cell sera, but the SxB2 was adsorbed with BF-2 cell lysate. These 
sera were left for 90 min. The SxB2 was added at 1:400 in PBSTO, left 90 min and the 
conjugate, AMD Bi2 HRP was added and left 90 min, before ABTS was added and 
allowed to react for 90 min and read at 405 nm. 
When RxBF-2 and RxRTG were both used to reduce background in the virus 
preparations, they did not effect the resulting optical densities of the virus positive culture 
supernatant, BF-2 cell lysate, or rainbow trout tissue homogenate. Only adsorption of 
SxB2 with BF-2 cell lysate reduced the resulting optical densities of BF-2 cell lysate as 
antigen (Table 4.10). 
c. The sheep-anti-B2 serum at 1:400 in 5 ml of PBS/ 0.05% Tween 80/ 0.1% gelatin 
was adsorbed with 0.6 mg/ml Mycobacterium phlei overnight at 4°C, and used as the 
second antibody in the ELISA (Appendix A). The results were compared with those 
obtained using the non-adsorbed'sheep-anti-B2 serum. A new batch of conjugate (AMD 
Bi2 HRP) was also used at 1:500 in PBSTO. Various rainbow trout tissue homogenates. 
cell culture supernatants, and rainbow trout tissue homogenates appearing as false 
positives in Appendix B ("false positives" as they came from virus free populations and 
virus isolation results were negative but ELISA OD were quite high, eg: OD of 1.0) were 
used as antigens. The preparation of these antigens is described in section 5.2.2. 
There was no difference in the OD obtained in the ELISA when using the rainbow trout 
tissue homogenates or the false positive rainbow trout tissue homogenates as antigens 
when M. phlei adsorbed SxB2 was employed. The resulting OD for the false positive 
rainbow trout tissue homogenates was very low in both cases. In an early ELISA (data not 
shown) the OD for these samples was between 0.8 and 1.0, whereas in this ELISA the OD 
were all close to 0.25. However, there was a significant reduction in the OD of samples 
where the sheep-anti-B2 serum was adsorbed with M. phlei (Table 4.11). 
4.3.4 Comparison of Original and Improved ELISA Methods 
The original format of the ELISA and the ELISA formatted after all changes had been 
made (see Appendix A) were carried out on the same plate, with many dilutions (dilutions 
are marked on Figure 4.8) of the viral antigen ranging from neat antigen to antigen diluted 
1:100 000 (TCID50 of lO'-lO') so that a comparison of the sensitivity of the two methods 
could be made. The improved method is about 40 times more sensitive than the original 
ELISA (Figure 4.8). In the original ELISA the OD dropped below 0.5 at an antigen 
dilution of about 1:16 (TCID^o = lOVml), whereas in the improved ELISA the OD did not 
drop below 0.5 until an antigen dilution of 1:600 which is very close to a TCID^o = lOVml. 
Table 4.11: Adsorption of sheep-anti-B2 serum with M. phlei. OD obtained from the 
ELISA when Sheep-anti-B2 serum, adsorbed and not adsorbed with 
M.phleiy was used as second antibody against various viral antigens on the 
ELISA. 
Viral antigens Non-adsorbed OD Adsorbed OD 
Cell culture SN 
92.11.1 2.09 1.82 
92.11.2 1.73 1.3 
92.11.3 2.2 1.68 
92.11.4 2.52 1.88 
92.11.2,3,4 2.39 1.42 
92.14.1 3.27 1.94 
92.14.2 3.24 2.26 
92.14.3 1.49 1.05 
92.14.4 2.71 2.11 
92.14.5 1.79 0.96 
92.14.6 3.22 2.26 
Homogenates 
92.15.4 1.3 1.29 
92.15.5 0.3 0.3 
92.15.6 0.55 0.49 
92.15.7 1.77 1.76 
92.19.145 0.95 0.91 
False positives 
92.9.36 0.28 0.26 
92.9.42 0.27 0.25 
92.9.79 0.25 0.25 
92.9.80 0.25 0.26 
Figure 4.8: Comparison of original and improved ELISA methods. OD obtained in the 
ELISA for many viral antigen dilutions using both the original and improved ELISA 
methods to see if sensitivity of the ELISA had improved with the changes made. 
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4.4 Discussion 
An indirect, antigen capture ELISA was developed for the detection of EHNV. The 
sensitivity of this assay was about 10^ TCIDjo/mi. This chapter has outlined the 
development of the ELISA from antibody production to a final method (Appendix A). 
There are many different techniques in use for the preparation of specific antisera against 
vimses. The inoculation schedule used to produce specific antibodies in sheep and rabbits 
against EHNV was successful, and was similar to one of the more successful methods 
used in a comparative study on production of antisera against fish viruses published by 
Hill et al. in 1981. The similarities were in the use of concentrated virus, rather than tissue 
culture supernatant, combining the virus with Freund's complete adjuvant, and an initial 
inoculation followed 4 weeks later by a booster of the same dose. Hill et al. (1981) used 
an intramuscular injection followed by an intravenous injection, while the present study 
used subcutaneous injections for both inoculations. This alteration however did not 
preclude the production of antisera. 
Sheep have not been used for the production of antisera against fish viruses as extensively 
as rabbits. Hill et al. (1981) noted that, even though the volume of sera produced is 
considerably less than in pigs or sheep, rabbits are by far the favoured animal. The sheep 
anti-B2 serum, produced in this project showed some reactivity against host cell antigens 
(Figure 4.2). This reactivity caused background in the ELISA, but this was reduced by 
adsorption with BF-2 cell lysate. Pre-adsorbing an antiserum can eliminate background 
reactivities with host protein antigens, and has been used in the development of other solid 
phase immunoassays for fish. For instance, Hsu and Leong (1985) pre-adsorbed a rabbit 
anti-infectious heamatopoietic necrosis virus (IHNV) serum with uninfected CHSE-214 
cells prior to use in protein immunoblots, and McAllister and Schill (1986) preadsorbed 
their rabbit antisera overnight on a monolayer of CHSE-214 cells. No heterologous 
reactions were observed in either of these studies after adsorption. Dixon and Hill (1984) 
were successful in adsorbing rabbit antisera raised against IHNV, but not against viral 
haemorrhagic septacaemia virus (VHSV), where serious background reactions occurred in 
the ELISA. The rabbit anti-B2 serum produced in the present study appeared to be free of 
host cell antibodies as was demonstrated by the immunoblotting results (Figure 4.1). It 
was, therefore, not adsorbed with BF-2 cell lysate before use. However, it was possible 
that adsorbing the rabbit-anti-B2 serum with the host cell lysate could have reduced the 
trapping of some host cell antigens on the plate. 
The rabbit-anti B2 serum was a more competent capture antibody than the sheep-anti-B2 
serum, and this was assumed to be due to the higher specificity for EHNV antigens that it 
demonstrated in immunoblots. It is possible that the rabbit immunoglobulin has greater 
affinity for the virus itself (Figure 4.1). It is also possible that the rabbit immunoglobulin 
has a greater affinity for the polystyrene microtitre plates used as the solid phase in the 
ELISA. Kemeny and Challacombe (1988) and Cantarero et al. (1980) have both stated that 
different proteins have different binding capacities for the polystyrene solid phase. When 
the sheep-anti-B2 serum was used as capture antibody, swine-anti-rabbit serum, HRP 
conjugated, was used to detect the second antibody. The quality of this serum could have 
contributed to this effect. 
Both rabbit and sheep sera were affinity purified because purification of polyclonal 
antibodies gives greater specificity by removing many of the unwanted activités which 
may arise by working with whole serum (Warr, 1982). Use of affinity purified rabbit 
anti-B2 immunoglobulin increased the sensitivity of the ELISA a hundred fold. This 
effect is most easily explained in terms of the density of anti-EHNV antibodies bound to 
the solid phase. When whole serum was used as a source of capture antibody, a plethora 
of irrelevelent serum proteins would have bound to the solid phase along with the specific 
antibodies. In contrast, only immunoglobulins were bound to the solid phase when affinity 
purified serum was used as a source of capture antibody. Affinity purified sheep anti-B2 
immunoglobulin marginally decreased the sensitivity of the ELISA. This was due, 
possibly, to the fact that the affinity purification was reliant on the strong immunoglobulin 
binding capacity of protein A which is only specific for certain mammalian 
immunoglobulin (Ig) classes and subclasses, especially IgG in guinea pigs and rabbits 
(Warr, 1982). Coding.(1978) and Goudswaard et al. (1978) demonstrated that not all the 
IgG subclasses from rats, goats, sheep and horses, will bind to protein A columns, and this 
can lead to poor recovery of antibody activity. In addition, the elution from protein A in 
low pH buffer may have damaged the specific sheep antibodies, reducing their binding 
affinity for EHNV in this study. 
The comparison of proteinaceous blocking agents showed that the use of a block 
decreased background effects, but there was little difference in the results with the 
different agents. Without a block there may be a tendency for extraneous material in the 
antigen solution to bind to the unoccupied sites on the solid phase and to be detected by 
the second antibody (Spencer, 1988). 
Choice of conjugate was important in formatting this antigen capture ELISA. Use of a 
monoclonal conjugate resulted in considerably greater sensitivity and specificity of the 
assay when compared to use of a polyclonal conjugate. This is obviously due to the 
greater specificity of monoclonal antibody for the sheep second antibody and a lower 
tendancy for non-specific binding of the monoclonal conjugate to the rabbit capture 
antibody. When the two enzymes, HRP and AP were compared there was no real 
difference in sensitivity or specificity, but the advantages of HRP are clear; it is pure, 
cheap, readily available, and a large number of chromogens are commercially available 
(Heytman, 1988). AP on the other hand is expensive, and more commonly used for 
detection in immunoblotting as it gives low backgrounds in this technique. A comparison 
was also made between conjugated monoclonal antibodies. AMD Bi2 AP was compared to 
Arimab AP, and AMD Bi2 HRP was compared to Arimab HRP. Again there was the same 
trend in results; no major difference was found between any of the conjugates. The AMD 
Bi2 is commercially available and used widely, whereas the Arimab is not. It was for 
these reasons that the AMD Bi2 HRP conjugate became the conjugate used for this 
ELISA. 
ABTS, OPD, and TMB are three of the preferred chromogens used in ELISA which are 
compatible with HRP conjugates. Heytman (1988), demonstrated that TMB was the most 
efficient in detecting low levels of enzyme, followed by OPD and then ABTS. When these 
chromogens were compared in the EHNV ELISA, no major difference was found in 
sensitivity between ABTS and TMB when antigen was present in low concentration, and 
OPD was only slightly more sensitive. As well as providing a sensitive detection method 
for enzyme assays, the substrate for the ELISA must also be cheap, safe and easy to use. 
OPD is considered to be a possible carcinogen, and OPD and ABTS are thought to be 
mutagenic (Heytman, 1988). TMB is the safest, however, ABTS is relatively safe if 
handled carefully, and is also the easiest to use as it is not light sensitive and can be 
prepared in advance and stored for long periods in frozen aliquots. Thus it was the chosen 
substrate for this system. 
It was shown that this ELISA could be done rapidly, ie: in under 4 hrs, and therefore be 
very useful as a rapid diagnostic test. 
Many infected and virus free tissue homogenates were put through the ELISA (chapt 5) 
and some of the virus free samples yielded an OD as high as 1.0. For this reason attempts 
were made to further reduce the interference by non-specific antigens. SxB2 serum was 
adsorbed with M. phlei. Further, RxRTG and RxBF-2 sera were reacted with the bound 
samples to reduce the number of non-specific binding sites available to bind to the sheep 
serum used as the second specific antibody in the capture assay. Mycobacterium occurs 
naturally in the environment and thus could be present in rainbow trout or redfin tissues. It 
is also present in the adjuvant used to induce antibody production for the SxB2 and RxB2 
sera, so antibodies against Mycobacterium could be present in these antisera and could 
react with the bacterial antigen, which may be present in the rainbow trout tissues. The 
results of this experiment were inconclusive as the false positives yielded a very low OD 
for both the M. phlei adsorbed and non adsorbed SxB2 sera in this series of tests. A new 
batch of AMD Bi2 HRP was used which could have influenced the results. 
The effect of RxRTG and RxBF-2 sera used as competitors for the non-specific antigens 
reacting with the sheep-anti-B2 serum was of little practical significance. The RxBF-2 
inclusion as a competitor, and also when RxBF-2 and RxRTG inclusion as blocks, 
increased the OD of the positive control only slightly (Table 4.10) and this was possibly 
due to the unmasking of viral epitopes due to the removal of stearic hindrances. The same 
inclusions had little effect on the background. This suggests that the background levels 
were not due to cross reactions with the rainbow trout tissues themselves and this is 
supported by the fact that there was no change in the OD of the rainbow trout 
homogenates. 
A comparison of the original ELISA method with the improved method (Figure 4.8) 
shows that most of these experiments were worthwhile as the assay sensitivity increased 
by 40 times, ie: the ELISA can now detect virus to a TCID50 of lOVml instead of lOVml. 
In assessing the format of this ELISA and the types and concentrations of reagents used, 
we were primarily concerned with maximisation of assay sensitivity under conditions 
where antigen is limiting. Interestingly, the crucial factors in the system turned out to be 
the nature of the capture antibody and conjugate, and not the enzyme or chromagen. 
An eariy protocol for the detection of EHNV by the above described ELISA was 
published in the Journal of Virological Methods (33: 199-209) and was based on data 
from this study (Steiner et al., 1991). 
Subsequent to this study, an antigen capture ELISA for EHNV has been described by 
workers at the Australian Animal Health Laboratory (Hyatt et al., 1991). In their ELISA 
the capture antibody was sheep antiserum raised to EHNV and purified from infected 
FHM cells. This was diluted 1:30 000 in 0.05M Tris-HCl pH 9, adsorbed overnight at 4°C 
and then washed with PBST 3 times. EHNV antigen was added and incubated for 1 hr at 
37°C in the presence of 2% skim milk in the PBST diluent and washed as above. Rabbit 
antiserum to either purified intracellular EHNV or capsid proteins was diluted 1:30 000 in 
PBST plus 2% skim milk and incubated for 1 hr at 3TC before washing as above. The 
conjugate, sheep-anti-rabbit (IgG)-HRP, was diluted 1:5000 in PBST containing 2% 
skim milk and added for 1 hr at 3TC. This was washed as above and TMB substrate was 
used. 
Viral antigens detected in the ELISA done by Hyatt et al. (1991) had titres of 2.4 x 10' 
pfu/ml for the redfin isolate and 4.3 x 10̂  pfu/ml for the rainbow trout isolate. Since the 
titre of the viral antigens used by Hyatt was determined using a different method to the 
method used to determine the titres of viral antigen in this study (ie: pfu/ml versus 
TCIDji/ml respectively) no concrete comparison of assay sensitivity between the two 
ELISAs can be made without further experimentation. It could be assumed that the 
sensitivity of the two methods is very similar. Hyatt et al. (1991) estimated the assay 
sensitivity by calculating the particle to infectivity ratio by an electron-microscopical 
particle count (200:1 for the rainbow trout isolate and 10:1 for the redfin perch isolate). 
Furthermore, they found that as little as 400 virus particles in 50 ul of sample could be 
detected on their EHNV capture ELISA at an OD of 0.14, indicating that they could detect 
viral antigen to a titre of 8x10^ particles/ml. They did not however produce any data for 
the determination of sensitivity^ or specificity of their ELISA in an epidemiological 
context. Results presented in Chapter 5 address these issues. 
5. Chapter 5 - Application and Assessment of Antigen Capture ELISA 
5.1 Introduction 
Many rapid detection methods for fish viruses have been established over the past decade, 
and many of these utilise ELISA. Dixon and Hill (1983) developed an ELISA to detect 
infectious pancreatic necrosis virus (IPNV) in salmonid fish, but found it was not as 
sensitive as virus isolation in cell culture. In 1984 Dixon and Hill developed another 
ELISA for infectious haematopoietic necrosis virus (IHNV) and ELISAs for two eel 
rhabdoviruses. Results were obtained in under two hours and although specific for all cell 
culture derived material the assays showed mild cross reactions when applied to extracts 
of infected fry. Attempts at assays for viral haemorrhagic septacaemia virus (VHSV) and 
spring viraemia of carp virus (SVCV) were unsuccessful due to low titred antibodies 
(Dixon and Hill, 1984). Kodak et al. (1988) also developed an ELISA for IPNV detection 
in rainbow trout, and found that they could detect IPNV at concentrations as low as 10' 
TCID5(/ml with good quality antisera. Way and Dixon (1988) developed rapid ELISAs for 
the detection of VHSV and IHNV. Both assays were specific for their respective virus, 
although the VHSV assay was the most sensitive, and the results could be obtained in 
under two hours. Mild cross reactions were present for both VHSV and IHNV. It should 
be mentioned that polyclonal antisera were used in all the assays described above. An 
antigen capture ELISA was developed for VHSV in 1990 by Mourton et al.. This assay 
employed two monoclonal antibodies and was highly specific, with no cross reactions to 
IPNV, IHNV, SVCV, pike fry rhabdovirus, eel rhabdovirus, or perch rhabdovirus, and is 
sensitive to 1 ng/ml of purified virus, 5x10^ pfu/ml of culture supernatant. Further, virus 
can be detected in organ extracts. 
All of the above mentioned viruses are highly infectious and spread quickly through 
cultured salmonid and other fish populations, sometimes causing mass mortalities in fry as 
well as considerable monetary losses. The diagnostic procedures available previously were 
usually, as in the case of EHNV, virus isolation techniques using cell culture which can 
take some days to weeks to give a result. The ELISA has proven to be an appropriate 
technique to replace this laborious method, as it is sensitive and specific when developed 
with care, and it can cope with many samples simultaneously. In this chapter the results of 
assessment of the ELISA developed in chapter 4 when applied to many field samples will 
be described. The ELISA was compared with virus isolation to obtain an estimate of 
sensitivity and specificity in the epidemiological sense. 
The ELISA must have well titred specific antibodies for good results, but to be applied to 
tissue samples from fish there must be a good method for releasing antigen from those 
tissues. In previous experiments virus was released from tissues by homogenisation in a 
blender. Blender homogenisation is the classic method described throughout the literature 
(Langdon, 1989; Kodak et al., 1988; and Dixon and Hill, 1983), although some workers 
homogenise with a chilled mortar and pestle. Either homogenising procedure appears to 
work well for virus isolation in cell culture. However different techniques for releasing 
virus from tissue for use as antigen in ELISA are used. Shannon et al. (1991), simply chop 
the tissue with fine scissors and'add 1% Nonidet P - 4 0 in PBS, vortex vigorously every 
half hour for two hours and obtain a good yield of virus after clarification. This method 
along with other virus release methods were assessed in this study to ensure that a 
maximum yield of virus was recovered from the tissues of the field samples, and that this 
was accomplished as efficiently as possible with respect to operator time, equipment 
available, and procedural ease. 
5.2 Methods 
5.2.1 Methods of Virus Release from Tissue 
5.2.1.1 Preparation of material to he used for virus release methods 
A large (27cm forklength) redfin perch was infected with a rainbow trout isolate of EHNV 
(86:8774) by bath exposure ie: 1ml of the stock virus (TCIDjo of lO'̂ '̂/ml) was added to 
the tank to give a concentration of about 1 virion/ml of water. This was followed by 
intraperitoneal injection of 100 |xl of the same stock virus on day 16. The fish died on day 
18. Multifocal hepatic necrosis was observed grossly (Figure 5.1) and microscopically 
(data not shown). Small parts of the liver, kidney, spleen and gonads were removed and 
placed at -20°C for virus isolation. The remaining liver was sliced into 2 mm' pieces 
which were mixed well and divided into 8 groups of about 0.4 g total weight each and 
frozen at -20°C until required. These liver samples were used in the following virus 
release method experiments: 
5.2.1.2 Nonidet P-40 (NP-40) 
About 0.2 g of liver was roughly minced in a 10 ml vacutainer and 1.25 ml of PBS with 
1% NP-40 was added to the tube. This suspension was vortexed vigorously every 30 min 
for 2 hrs. The debris was pelleted at 2000 rpm (900 g) for 10 min, and the supernatant 
Figure 5.1: Dissected Redfin. A dissected RF showing the intact gill opercula, liver with 
hepatic necrosis (yellow spots) from EHNV, and normal gonads. A liver similar to this 
one was used for all virus release methods. 
\S\i-9\ 
(SN) saved at 4°C until assayed. 
5.2.1.3 Liquid nitrogen and tissue grinder 
About 0.2 g of liver was roughly minced with fine scissors in an eppendorf tube (El), 
frozen in liquid nitrogen with 0.94 mg of glass beads (0.75 mg/ml of 106 îni glass beads), 
and ground with a fitted pestle (Edwards Instrument Company, Sydney, Australia). PBS 
was added (1.25 ml) and mixed, and this suspension was vortexed vigorously for about 
20 sec every 30 min for 2 hrs. The debris was pelleted at 2000 rpm (900 g) for 10 min, 
and the SN saved at 4°C. 
5.2.1.4 Glass beads and sonication 
About 0.2 g of liver was roughly minced with fine scissors in a 10 ml vacutainer and 1.25 
ml of PBS was added along with 5 glass beads approximately 5 mm in diameter. This was 
sonicated for three 1 min cycles and vortexed vigorously for about 20 sec every 30 min 
for 2 hrs before the debris was pelleted at 2000 rpm (900 g) for 10 min, and the SN stored 
at 4°C until assayed. 
5.2.1.5 Homogenising 
About 0.4 g of liver was roughly minced with scissors in a small blending homogeniser 
and 2.5 ml of PBS was added. This was homogenised for 30 seconds and let sit at 4°C for 
2 hrs, with vigorous vortexing for about 20 sec every 30 min. The debris was pelleted at 
2000 rpm (900 g) for 10 min and the SN was stored at 4°C. 
Figure 5.2: Tissue grinders and glass beads used in virus release methods. The tissue 
grinders (blue ET and pestle) used in virus release method 5.2.1.7 a. The second 
photograph shows the 5 mm glass beads being added to the tube aseptically before 
vortexing. 
5.2.1.6 Tissue grinding 
About 0.2 g of liver was roughly minced with fine scissors in an eppendorf tube and 
ground with a fitted pestle (Edwards Instrument Company, Sydney, Australia). PBS was 
added (1.25 ml) and the suspension was vigorously vortexed for about 20 sec every 30 
min for 2 hrs, before the debris was pelleted at 2000 rpm (900 g) for 10 min, and the SN 
stored at 4°C. 
All of the SN virus release methods were titrated by dilution in the ELISA developed in 
chapter 4 (see Appendix A). 
5.2.2 Virus Isolation 
The organs from fish were removed aseptically and stored in duplicate tubes at -20°C. 
These organs were thawed, homogenised in a blending homogeniser in the proportion of 1 
g in 10 ml homogenising media (growth media (section 2.2) without the PCS). The 
homogenates were placed at 4°C for 2 hrs, then clarified three times by centrifugation at 
2000 rpm (900 g) for 10 min in an EEC Centra 7 centrifuge. All samples received after 
November, 1991 were treated with the most appropriate virus release method which was 
determined to be the method described in section 5.2.1.7.a.(see page 81). A 200 m-1 volume 
of each homogenate was inoculated neat, in duplicate, into tissue culture tubes (Kimex, 
Flow, Sydney, Australia) containing a monolayer of BF-2 cells, and 200 \x\ of 
homogenate diluted 1:10 in media was inoculated into a third tube. Tubes were incubated 
at 22-24°C and checked periodically until day seven. If no cytopathic effect developed to 
give an indication of the presence of virus then the tubes were frozen at -20°C overnight 
to lyse the cells, and 100 from each tube was passed to fresh tubes of BF-2 cells after 
thawing at RT. This was repeated a third time only if cell morphology was not healthy, 
and CPE was not detectable. Homogenates were stored at -20°C after inoculation. 
ELISA (for method see Appendix A, final method) was carried out on all homogenates, 
and all supematants from cell culture. Homogenates of samples received after November, 
1991 were tested neat and at a 1:10 dilution in PBSTO. The dilution was carried out in the 
microtitre plates using an eight channel pipette. Eight controls were used on each ELISA 
plate. Of these, 6 were prepared from a positive stock of a rainbow trout isolate of EHNV 
as prepared in section 2.4 and diluted 1:10, 1:100, 1:200, 1:500, 1:1000 and 1:10000 in 
homogenising media. Two rainbow trout liver homogenates determined to be free of 
EHNV by virus isolation and polymerase chain reaction (PCR) (PGR carried out at 
AAHL, Geelong) were also included. 
5.2.3 Source of Infected and Uninfected Fish 
a. Infected fish: Rainbow trout were collected from natural outbreaks of EHNV and redfin 
perch were also collected from natural outbreaks and fish from experimental infections 
were used also. 
b. Uninfected fish: Rainbow trout from Tasmania, which is known to free of EHNV, and 
from Gaden hatchery, Jindabyne, NSW, where there has never been any clinical evidence 
of EHNV and where annual certification by virus isolation has been conducted, were used. 
5.2.4 Analysis of Results 
The controls from each plate (100 plates total) were averaged respectively, and a standard 
deviation and coefficient of variation for each control was calculated. 
Sensitivity of the ELISA was calculated using individually tested samples where virus 
isolation had been conducted on these individual fish and was positive in first, second or 
third passage. Specificity of the ELISA was calculated from samples from known EHNV 
free populations where virus isolation was negative on pools of 1-5 fish. These data were 
analysed using Minitab statistical software on an IBM computer. Dotplots and histograms 
were used to plot the OD results from infected and non-infected populations so that the 
specificity and sensitivity of the ELISA could be determined. All raw data used for these 
analyses are listed in Appendix B. 
5.3 Results 
5.3.1 Virus Release Methods 
Method 5.2.1.4 (glass beads (GB) and sonication) appeared to be the method which 
released the most virus as ELISA OD were higher for viral antigen dilutions 1:100 to 
1:6000, than for the methods 5.2.1.2, 5.2.1.3, 5.2.1.5 and 5.2.1.6 (Table 5.1). 
Methods 5.2.1.4 and 5.2.1.6 were repeated in another experiment, together with the 
follwing modifications of the two methods: 
a. Tissue grinder and 5 mm glass beads in an ET. 
b. Tissue grinder and transfer with 5 mm glass beads to a glass tube. 
c. Tissue grinder and 106 ^m glass beads in an ET. 
About 0.2 g of liver was roughly minced with fine scissors for each of these trials. PBS 
was added (1.25 ml) and 3x5 mm glass beads or 0.75 mg/ml of 106 \im glass beads were 
added. This suspension was vortexed vigorously for about 20 sec every 30 min for 2 hrs, 
Table 5.1: Comparison of OD for virus release methods. OD 
obtained in ELISA when evaluating the original five methods to 
release virus from tissues. Affinity purified rabbit-anti-B2 
serum was capture antibody, sheep-anti-B2 serum was second 





GB+Sonic Homog TG 
1:100 2.09 2.38 2.68 2.07 2.35 
1:1000 0.41 0.60 0.99 0.53 0.50 
1:2000 0.27 0.29 0.55 0.29 0.33 
1:4000 0.20 0.23 0.34 0.23 0.24 
1:6000 0.18 0.19 0.27 0.20 0.20 
1:8000 0.16 0.18 0.23 0.15 0.17 
1:10000 0.17 0.16 0.19 0.15 0.20 
Table 5.2: Comparison of OD for modifications to virus release 
methods. OD obtained in ELISA for repeat and modified virus 
release methods. Affinity purified rabbti~anti-B2 serum was 
capture antibody, sheep-anti-B2 serum was second antibody and 
mouse-anti-sheep-HRP was conjugate. 
Viral Ag 
dilution 
GB+Sonic TG TG+BBinET TG+BBinGT TG+LBinE 
T 
1:100 2.44 2.22 2.42 2.48 1.94 
1:1000 0.95 0.67 0.99 1.08 0.67 
1:2000 0.57 0.4 0.58 0.66 0.43 
1:4000 0.34 0.21 0.32 0.39 0.25 
1:6000 0.25 0.19 0.26 0.29 0.2 
1:8000 0.19 0.14 0.2 0.23 0.17 
1:10000 0.17 0.13 0.17 0.2 0.14 
before the debris was pelleted at 2000 rpm (900 g) for 10 min, and the SN stored at 4°C. 
When the virus preparations obtained using methods 5.2.1.4, 5.2.1.6 and modified methods 
5.2.1.7 a - c were tested by the ELIS A there was no difference in the resultant OD of 
preparations from methods 5.2.1.4 (glass beads and sonication), 5.2.1.7 a (tissue grinder 
and glass beads in an ET) and 5.2.1.7 b (tissue grinder and glass beads in a glass tube). 
These methods appeared to release more virus as the preparations gave higher ELISA OD 
than methods 5.2.1.6 and 5.2.1.7 c (Table 5.2). As there was no real difference between 
the results of methods 5.2.1.4, 5.2.1.7 a and 5.2.1.7 b, method 5.2.1.7 a was chosen for all 
further virus isolation work because of its relative procedural ease. 
5.3.2 Analysis of ELISA Precision Between Plates 
The coefficient of variation was greater than 25% for each control tested over 100 plates, 
in 22 separate assays over 6 months (Table 5.3). This variation was attributed to timing 
inconsistencies in substrate incubation, batch to batch variations in conjugate, and 
deterioration of the controls themselves over time. 
5.3.3 Analysis of Sensitivity and Specificity of the ELISA 
The raw data for virus isolation and ELISA results for all fish tested is listed in Appendix 
B. 
Firstly, statistical analysis (t test) of the infected and uninfected populations showed that 
there was a significant difference between ELISA optical densities (OD) of these 
populations (Table 5.4). 
Table 5.3: Analysis of ELISA 
precision between plates. 
Controls 1:10 1:100 1:200 1:500 1:1000 1:10000 RT-68A RT-68B 
Mean 2.13 0.99 0.55 0.22 0.17 0.13 0.29 0.31 
STDV 0.77 0.48 0.27 0.09 0.07 0.05 0.09 0.08 
CV 36.0 47.8 48.5 43.0 37.3 35.3 32.1 25.3 
Sample size 56 99 99 99 99 99 99 99 
Table 5.4: Results of statistical analysis of ELISA OD of 
infected and uninfected RT and RF populations. The 
positive population consisted of OD from samples 
individually found to be infected with EHNV by virus 
isolation. The negative population consisted of OD from 
samples from fish populations known to be free of EHNV 
and confirmed to be uninfected by virus isolation of pools of 
5 fish. 
Samples Samples size Mean P value 
All neat positive homogenates 55 2.103 0 
All neat negative homogenates 348 0.291 
All dilute positive homogenates 21 2.08 0 
All dilute negative homogenates 250 0.167 
RF neat positive homogenates 29 1.917 0.14 
RT neat positive homogenates 26 2.311 
RF dilute positive homogenates 10 2.78 0.0026 
RT dilute positive homogenates 11 1.39 
RF neat negative homogenates 87 0.12 0 
RT neat negative homogenates 261 0.35 
RT neat negative homogenates 250 0.35 0 
RT dilute negative homogenates 261 0.167 
Neat positive homogenates 55 2.103 0.85 
Dilute positive homogenates 21 2.05 
RF dilute positive homogenates 29 2.78 0.0001 
RF neat positive homogenates 10 1.917 
RT dilute positive homogenates 11 1.39 0.032 
RT neat positive homogenates 26 2.311 
RF = redfin perch RT = rainbow trout 
In particular: 
a. There was no significant difference between the OD of infected redfin perch and 
infected rainbow trout homogenates tested neat, however there was a significant difference 
between the OD of redfin perch and rainbow trout homogenates tested at 1:10 dilution. 
Infected redfin perch had greater OD than infected rainbow trout tested at 1:10. 
b. There was a significant difference between the OD of uninfected redfin perch and 
uninfected rainbow trout homogenates. The uninfected rainbow trout had a higher OD than 
the uninfected redfin perch; 
c. Dilution of uninfected rainbow trout homogenates resulted in a significant reduction in 
OD; 
d. Using infected fish, the OD of the neat redfin perch homogenates was significantly less 
than that of the homogenates which were diluted 1:10; while 
e. OD of the rainbow trout homogenates diluted 1:10 was significantly reduced compared 
with neat homogenates; 
f. There was a significant difference between the OD of supernatants (SN) of positive and 
negative cultures. 
The analysis of the dotplots and histograms gave values for specificity and sensitivity of 
Table 5.5: Estimate of specificity and sensitivity of the ELISA 
obtained using dotplots and histograms of OD results from 
infected and uninfected fish. 
Sample P/N Cutoff No. 
Positive 
No. Negative Total no. Sens (%) Spec (%) 
All neat bomogenates 0.95 45 10 55 81.2 IP 
4 344 348 98.9 UP 
All dilute bomogenates 0.55 17 4 21 81 IP 
0 250 250 100 UP 
RF neat bomogenates 0.95 23 6 29 79.31 IP 
0 87 87 100 UP 
0.55 25 4 29 86.2 IP 
0 87 87 100 UP 
RT neat bomogenates 0.95 22 4 26 84.6 IP 
4 257 261 98.5 UP 
0.55 24 2 26 92.3 IP 
69 192 261 73.6 UP 
RT dilute bomogenates 0.55 7 4 11 63.6 EP 
0 250 250 100 UP 
All neat SN 0.55 157 7 164 95.7 IP 
23 332 355 93.5 UP 
0.75 157 7 164 95.7 IP 
2 353 355 99.4 UP 
Key: IP = Infected population 
UP = Uninfected population 
the antigen capture ELISA (Table 5.5), when analysed with respect to: 
a. the OD of all neat and all dilute homogenates regardless of species; 
b. the OD of rainbow trout homogenates tested neat and dilute; 
c. the OD of redfin perch homogenates samples tested neat; 
d. the OD of all SN regardless of species or passage number; 
e. all of the above a-d , with a variety of P/N cutoff points. 
For all homogenates tested neat, a P/N cutoff OD of 0.95 was selected, resulting in a 
sensitivity of 81.2% and specificity of 98.9%. Frequency distributions (as dotplots) of this 
data are shown in Figure 5.2. Similar estimates of sensitivity and specificity were obtained 
for all homogenates tested at a dilution of 1:10 at a P/N cutoff OD of 0.55 (81%, 100%, 
respectively) (Table 5.5) (Figure 5.3). 
Selection of a P/N cutoff OD of 0.95 for neat homogenates resulted in sensitivity and 
specificity estimates of approximately 80% and 100% respectively for data analysed 
according to species (Table 5.5). Sensitivity for redfin perch samples was increased to 
86% by reducing the P/N cutoff OD of neat samples to 0.55 without compromising 
specificity. 
Sensitivity for rainbow trout samples tested dilute was only 63.6% at a P/N cutoff OD of 
0.55. In this group, 5 fish had virus isolated only in the second passage, ie: these fish 
contained relatively small amounts of virus (Appendix B). 
At a P/N cutoff OD of 0.75, sensitivity and specificity for culture supematants were 
Figure 5.3: Frequency distribution of the OD of neat tissue homogenates from 
infected and uninfected populations. 
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Figure 5.4: Frequency distribution of the OD of dilute tissue homogenates from 
infected and uninfected populations. 
'-ODdP 
Each dot represents 9 points 
0 . 0 0 
+• 








— O D d N 
95.7% and 99.4% respectively. 
5.4 Discussion 
Before the comparison of virus isolation and ELISA could be ascertained, two other issues 
needed investigation. The first was to determine the best method for the release of virus 
from tissues. Homogenising tissues with a blender was giving satisfactory results, 
however, it was unclear whether this procedure was giving the greatest possible yield of 
virus, and it was also inconvenient when the number of samples to be tested was in the 
hundreds. Of the various methods attempted in the first experiment (methods 5.2.1.2 -
5.2.1.6), the most successful with regard to ELISA OD (assay sensitivity) was method 
5.2.1.4 (glass beads and sonication), but the most convenient method was method 5.2.1.6 
(tissue grinding). As a result of this both methods were modified. The most procedurally 
convenient (time, cost, etc.) method that released the most virus was method 5.2.1.7 a. 
(tissue grinding and glass beads in an ET). The mini tissue grinders are convenient as they 
are cheap and disposable, and 100-200 samples can be prepared in a day. The addition of 
glass beads after grinding the tissue, along with vigorous vortexing appears to increase the 
amount of virus released compared favourably with homogenisation. This method made 
the time consuming task of tissue preparation for ELISA a little less arduous. The range of 
virus release methods were not evaluated tissue culture detection, only by ELISA. 
The second problem to be overcome was that of assay precision. Eight controls were used 
on each plate. Major variations in the OD of these controls occurred from day to day. The 
coefficient of variation for these controls was as great as 51.75%, and usually greater than 
25%. Raw data was used for all the analysis in this chapter. Despite the magnitude of 
variation in the control samples, statistically and biologically significant results were 
obtained for the test samples. Due to the possibility of antigenic deterioration of the 
controls, a problem experienced at AAHL, Geelong (A. Hyatt pers com to R. Whittington) 
various mathematical procedures for correction of interassay variation were not attempted. 
Further research is required to improve assay precision. The causes of the variation were 
likely to be timing inconsistencies during incubation steps, and variability induced by 
different batches of conjugate. 
After statistical analysis of all homogenate data, various conclusions could be drawn. 
Although there was no significant difference between OD of neat, infected redfin perch 
and rainbow trout homogenates, there was a significant difference between the OD of 
redfm perch and rainbow trout homogenates that were diluted 1:10. This was because 
there were five rainbow trout homogenates which were not virus isolation positive until 
the second passage and thus gave low ELISA OD. Sample numbers 274, 279, 282, 803, 
1007, (Appendix B), were samples which did not develop CPE until the second passage 
through cell culture ie: the virus was slow to express itself probably because the amount 
of virus present was low. In these homogenates the level of virus was below the threshold 
of this ELISA sensitivity. 
There was a significant difference between the OD obtained when testing neat uninfected 
redfin perch and rainbow trout homogenates, the latter yielding higher OD. It is possible 
that this was due to cross reacrions occurring in the ELISA between the rainbow trout 
tissue and the second antibody, sheep-anti-B2 serum. It is not known, however what these 
cross reactions are due to. They were not removed by competitive treatments with antisera 
specific for BF-2 and/or RTG cells and did not appear to be due to cross reactions with 
mycobacterial antigens as adsorption of the sheep-anti-B2 serum with mycobacterium had 
no effect. 
Another conclusion that was drawn from the statistical analysis of results was that there 
was no significant difference between the OD of neat and dilute positive homogenates if 
no account of species was made,ie: data from all types of fish were pooled before the 
comparison was made. However, there was a significant difference between the OD of the 
neat and dilute infected redfin perch homogenates, and also between the neat and dilute 
infected rainbow trout homogenates. With the redfin perch homogenates this is of no 
consequence because the mean OD of the dilute positives were greater than that obtained 
for the neat positive samples, suggesting a prozone effect. The virus positive rainbow 
trout homogenates, however, suffered a reduction in OD with diluting, resulting in a 
reduction in test sensitivity. There was no benefit in diluting rainbow trout homogenates as 
sensitivity decreased without a great increase in specificity. 
All of this information suggests that the tissues of infected redfin perch harbour more 
virus than do those of rainbow trout. This is quite a feasable assumption as EHNV has a 
more severe effect on redfin perch than on rainbow trout. 
The specificity and sensitivity of this ELISA were generally quite high. The lowest 
estimate of sensitivity was 63.6% for the dilute rainbow trout homogenates and was due 
to the late responders in virus isolation, 274, 279, 282, 803, 1007, ie: those samples which 
did not develop CPE until the second passage through cell culture and thus gave low OD 
in the ELISA for homogenates (Appendix B). 
There are no data in the literature, with regard to antigen capture ELISA for detection of 
fish viruses, which refers to specificity and sensitivity in the epidemiological sense. The 
only data relate to assay sensitivity and it uses the lowest titre of virus which can be 
detected, for instance, 10^ TCIDj^/lOO fxl is the sensitivity of the ELISA developed by 
Rodak et al., 1988. This compares only to the assay sensitivity, 10' TCIDjo/ml, described 
in chapter 4 for this antigen capture ELISA. The ELISA developed at AAHL, Geelong 
referred to in Chapter 4 has not been evaluated and there are no data on its sensitivity and 
specificity (A. Hyatt, personal communication to R. Whittington). 
The P/N cutoffs chosen for this ELISA, namely OD of 0.95 and OD of 0.75 for 
homogenates and supematants respectively, are relatively high. However, the ELISA was 
titrated for maximum assay sensitivity (S/N ratios) on serially diluted culture supematants. 
The high background levels of negative rainbow trout tissues necessitated a high P/N 
cutoff, but this did not adversely affect the utility of the test. There may be merit in 
investigating the use of antiviral monoclonal antibody, as second antibody, to reduce 
background signals. 
The 80% sensitivity and > 98% specificity of the ELISA appear adequate for diagnostic 
screening of test samples from populations of fish, particularly if used to determine 
presence or absence in several fish in the population to be studied. In some cases the 
ELISA appeared to be more sensitive than virus isolation, as on 18 occasions it yielded a 
positive result in samples from infected populations when virus isolation results were 
negative (Appendix C). This suggests that in some instances non-culturable virus maybe 
present in infected fish that can be detected by ELISA. In conclusion, this ELISA will be 
a useful tool for epidemiological studies of EHNV and for routine diagnosis of the 
disease. 
6. General Discussion 
In summary, it was found that EHNV is grown successfully in BF-2, RTG and FHM 
cells, however, BF-2 cells were the most convenient cells to use due to the robust nature 
of the cells and the shorter culture times. A temperature range of 20-24°C was found to 
produce the highest yield (about 10' TCIDjo/ml) of EHNV in BF-2 cells. The temperature 
used for subsequent viral culture was 22°C. Uninfected BF-2 cells could grow at 
temperatures up to 28°C. 
Purification of EHNV was achieved by differential and density gradient centrifugation. 
This method was modified from methods that had been used to purify FV3, an iridovirus 
thought to be closely related to EHNV (Vilagines and McAuslan, 1970; Tan and 
McAuslan, 1971; Aubertin et al, 1973; Braunwald, 1979; and Aubertin, 1980). SDS-
PAGE, western transfer and immunostaining with rabbit-anti-BF-2 serum showed EHNV 
purified to homogeneity with almost no cellular contamination. Alternate methods of 
purification such as various types of chromatography were not investigated in these studies 
and could be the scope of future experiments to determine the most efficient protocol for 
EHNV purification. Organic solvent extraction is unsuitable for the purification of EHNV 
due to the presence of lipoproteins which are adversely affected by ether. 
Purified B2 virus was successfully used to produce specific anti-EHNV antibodies in a 
sheep and a rabbit. The rabbit-anti-B2 serum was more specific than the sheep-anti-B2 
serum which showed cross reacting antibodies against BF-2 cells. During the development 
of the indirect antigen capture ELISA for the detection of EHNV cross reacting antibodies 
were removed by adsorbing the sheep-anti-B2 serum with a BF-2 cell lysate. This 
reduced background absorbance to an optical density less than 0.2 and slightly increased 
the signal from the virus samples. Other factors which contributed to an increase in assay 
sensitivity when formatting the ELISA were the use of a monoclonal conjugate and 
affinity purification of the capture antibody, rabbit-anti-B2 serum. The assay sensitivity, 
after formatting, had increased from 10'® TCID^yml during initial testing to 10' TCIDjo/ml 
after improvements. This result is comparable with the lOVlOO [il TCID^o of Kodak et al. 
(1988) discussed in chapter 5. Each component in the ELISA was tested for assay 
specificity and all were found to have no significant cross reactions. It was not possible, 
due to quarantine restrictions, to import viruses such as FV3 from AAHL (Geelong, Vic.) 
and a toad virus (Bohlivirus) from James Cook University (Townsville, Qld.). Therefore 
no experiments were carried out to test the assay specificity for the target virus. 
For the routine application of general diagnostic assays the virus has to be effectively 
released from fish tissues. Homogenisation, although widely used throughout the majority 
of diagnostic laboratories for virus release, was impractical and inefficient, especially 
when processing many samples of small fish. Glass beads and sonication appeared to 
release more virus in experiments carried out in chapter 5, however, tissue grinding was 
the most efficient method, ie: it released almost as much virus as glass beads and 
sonication and was the quicker and easier method. More experiments were carried out to 
combine these two methods. A successful combination arrived at, and used for the 
subsequent screening of 1600 fish, was the grinding of tissue with a fitted pestle in an 
eppendorf tube, addition of glass beads, vortexing and centrifugationto clarify the 
homogenate. These homogenates were inoculated into cell culture and passaged 3 times 
for virus isolation. Each homogenate was tested by ELISA, as were the culture 
supematants from these virus isolation studies in order to compare the methods. 
Sensitivity and specificity were evaluated in an epidemiological context from these results. 
The positive/negative cutoff optical densities chosen for the ELISA were 0.95 and 0.75 
respectively for the homogenates and the culture supematants. Using these cutoffs the 
sensitivity was 80% and the specificity >98%. On 18 occasions the ELISA gave positive 
results suggesting the presence of virus, and thus suggesting the ELISA more sensitive 
than virus isolation. It therefore appears that this ELISA is well suited for diagnostic 
screening of fish populations, providing an adequate sample size is tested, and also for 
epidemiological studies of EHNV. 
Apart from epidemiological surveys, further work to improve the ELISA should address 
problems of background absorbance mainly present when testing tissue extracts of rainbow 
trout. This would reduce the positive/negative cutoffs, and increase the sensitivity of the 
ELISA. This could be done with adsorption experiments or by the addition of competitive 
steps in the ELISA. The development of a monoclonal antibody specific for the virus may 
also reduce background effects and increase the specificity and sensitivity of this antigen 
capture ELISA. 
7. Appendix A 
Antigen Capture ELISA 
The polystyrene microtitre plate (Linbro) was coated with rabbit-anti-B2 serum diluted 
1:800 in BCB at 100 ^il/well. 
This was incubated overnight at and washed 5 times with distilled water/ 0,05% 
Tween 20 (WB) 
Unoccupied sites were then blocked with 1% ovalbumin in PBST, left for 30 min at RT, 
and washed as above. 
The antigen (prepared in chapt 4 & 5) was added as per methods and left for 90 min, 
removed in the laminar flow cabinet to be autoclaved, rinsed twice in the cabinet and 
washed as above. 
The second antibody, sheep-anti-B2 serum, was diluted 1:400 in PBSTO and added at 
100 jAl/well, left for 90 min at RT, and washed as above. 
The conjugate, AMD Bi2 HRP, was diluted 1:500 in PBSTO and added at 100 ^xl/well, 
left 90 min at RT, and washed as above. 
The substrate, ABTS + concentrated H^O ,̂ was added at 100 |il/well and shaken for 20 
min at RT, and read at 405 nm. 
Before and during some of the optimisation experiments of Chapter 4, the initial dilutions 
of the antibodies were as follows: 
CAPTURE ANTIBODY: 1:200. 
SECOND ANTIBODY: 1:200. 
CONJUGATE: 1:500. 
The final concentrations after all optimisation experiments were: 
CAPTURE ANTIBODY: 1:800, Affinity purified rabbit-anti-B2 serum. 
SECOND ANTIBODY: 1:400, Sheep-anti-B2 serum. 
CONJUGATE: 1:500, AMD Bi2 HRP. 
Appendix B 
Key Yr No Sub Specie? Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 OdpS Comraentl 
EHNV INFECTED POPULATIONS 
2 98 14 RF 18 1 L 0.28 P p P Stock EMAI 
4 98 2S RF 30 L 0.16 P p p Stock EMAI 
56 99 24 46 RF- 56 3 WF 0.23 n p 2.76 Blowering 
57 90 24 47 RF 56 3 WF 0.27 n p 0.54 Blowering 
58 90 24 48 RF 56 3 WF 1.55 P P 2.78 Blowering 
59 90 24 49 RF 56 3 WF 0.43 • P P 2.00 Blowering 
56 90 24 50 RF 56 3 WF 1.00 P p 2.91 Blowering 
61 90 24 51 RF 56 3 WF 0.84 d p 0.77 Blowering 
63 98 24 53 RF 56 3 WF 2.03 d p 2.54 Blowering 
65 90 24 55 RF 56 3 WF 1.99 d P 2.62 Blowering 
156 91 42 1 RF 72 1 LS6 2.21 P P p 2.37 2.86 3.04 EHNV3.91 
157 91 42 2 RF 72 1 LSG 2.74 P p p 2.74 2.87 2.71 EHNV3.91 
158 91 42 3 RF 72 1 LS6 2.97 P p p 2.85 2.90 2.89 EHNV3.91 
159 91 42 4 RF 72 1 LSG 2.78 P p p 2.89 2.90 2.85 EHiW3.91 
168 91 42 5 RF 72 1 LSG 2.90 P P p 2.80 2.84 2.94 EHNV3.91 
161 .91 42 6 RF 72 1 LSG 2.71 P p P 2.73 2.85 2.84 EHNV3.91 
185 91 2 8 RF 75.86 3 LS 1.00 cyt P p 2.62 2.81 Burrinjuck 
187 91 2 10 RF 75.86 3 LS 0.42 cyt P p 1.18 2.70 Burrinjuck 
189 91 2 12 RF 75.86 3 LS 2.29 cyt p p 1.77 1.75 Borrinjuck 
196 91 2E»05 RF 75.86 3 LS 2.60 n p P 2.14 2.55 EHNV1.91 
199 91 50 RF 75.86 1 L 1.65 n p p 2.07 2.57 Jaws3 
274 92 10 81 RT 112 1 LS 0.17 0.11 cyt P 8.98 2.02 SMT 
279 92 11 1 RT 112 1 LKS 1.83 0.25 n P 8.37 2.45 SMT 
289 92 11 2 RT 112 1 LKS 2.99 1.91 P P 1.16 2.43 SMT 
281 92 11 3 RT 112 1 LKS 2.98 2.48 P P 1.75 2.73 SHT 
282 92 11 4 RT 112 1 LKS 2.91 0.88 P P 1.54 2.85 SMT 
384 92 15 PI RT 117 5 LKS cyt p cyt n 2.41 2.76 SMT 
387 92 15 PI RT 117 2.94 2.83 cyt P 1.99 2.11 SMT 
389 92 15 P2 RT 117 5 LKS 2.88 2.97 P p cyt n 0.97 2.68 SMT 
394 92 15 P3 RT 117 5 LKS P p 2.59 2.78 SMT 
399 92 15 P4 RT 117 5 LKS P p 1.74 2.22 SMT 
424 92 15 P9 RT 117 5 LKS P P 1.79 2.51 SMT 
429 92 15 P10 RT 117 5 LKS P p 2.47 2.79 SMT 
434 92 15 Pll RT 117 5 LKS cyt p 2.74 2.55 SMT 
439 92 15 P12 RT 117 5 LKS P p 2.67 2.58 SMT 
444 92 15 P13 RT 117 5 LKS P p 2.19 2.36 SMT 
449 92 15 P14 RT 117 5 LKS p p 2.65 2.40 SMT 
454 92 15 P15 RT 117 5 LKS p p 1.32 2.62 SMT 
459 92 15 P15 RT 117 5 LKS p p 2.43 2.62 SMT 
464 92 15 P17 RT 117 5 LKS p p 2.47 2.67 SMT 
469 92 15 P18 RT 117 5 LKS p p 1.95 3.28 * SMT 
474 92 15 P19 RT 117 5 LKS p p 2.29 2.32 ' t SMT 
479 92 15 P20 RT 117 5. LKS p p cyt n 2.48 2.74 SMT 
484 92 15 P21 RT 117 5 LKS p p 2.39 2.36 SMI 
489 92 15 P22 RT 117 5 LKS p P 2.67 2.59 SMT 
494 92 15 P23 RT 117 5 LKS p P 2.37 2.65 SMT 
499 92 15 P24 RT 117 5 LKS p P 2.99 2.54 SMT 
594 92 15 P25 RT 117 5 LKS p P 2.55 2.53 SMT 
Key Yr No Sub Species Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 Odp5 Commenti 
599 92 15 P26 RT 117 6 LKS P P 2.45 2.16 SHT 
689 92 17 PS RT 117 5 LKS n P cyt n 9.49 2.39 SMT 
899 92 17 P7 RT 117 5 LKS P P •cyt n 2.85 2.52 SMT 
799 92 17 P7 - RT 117 2.72 2.31 cyt P 2.28 2.18 SMT 
719 92 17 Pll RT 117 5 LKS n P cyt n 2.16 2.77 SMT 
799 92 17 P27 RT 117 5 LKS P P cyt n 9.29 2.63 SMT 
893 92 17 P27 RT • 117 9.54 9.23 cyt P 9.41 1.51 SHT 
989 92 17 P29 RT 117 5 LKS P P cyt n 1.46 2.84 SMT 
969 92 14 1 RT 117 1 Ihl-S 2.99 P P 2.79 2.51 SMT 
979 92 14 2 RT 117 1 LKV/-S 2.79 • P P 2.71 2.85 SMT 
971 92 H 3 RT 117 1 LK»/-S 1.15 P P 2.39 2.73 SHT 
972 92 14 4 RT 117 1 LK»/-S 3.13 P P 2.64 2.74 SHT 
973 92 14 5 RT 117 1 LK+/-S 1.39 P P 2.47 2.75 SMT 
974 92 14 6 RT 117 1 Ihl-S 2.96 P P 2.84 2.81 SMT 
975 92 14 7 RT 117 1 LKf/-S 2.79 P P 2.71 2.89 SMT 
976 92 14 8 RT 117 1 LK+/-S 2.96 P P 2.68 2.82 SMT 
977 92 14 9 RT 117 1 LK+/-S 2.87 P P 2.59 2.75 SMT 
978 92 14 19 RT 117 1 LK+/-S 2.85 P P 2.79 2.75 SMT 
979 92 14 11 RT 117 1 LK»/-S 3.92 P P 2 . 7 7 2.74 SMT 
989 92 14 12 RT 117 1 LK»/-S 2.97 P P 2.65 2.74 SMT 
981 92 14 13 RT 117 1 LK+/-S 2.89 P P 2.49 2.36 SMT 
933 92 14 15 RT 117 1 LK^/-S 1.16 P d 1.92 2.19 SMT 
988 92 14 18 RT 117 1 LK^/-S 2.75 P P 2.69 2.77 SMT 
987 91 69 1 RF 119 1 LSG 2.84 2.88 cyt P 1.52 2.35 EHNV7.91 
988 91 69 2 RF 119 1 LSG 2.89 2.88 cyt P 9.99 1.78 EHNV7.91 
989 91 69 3 RF 119 1 LSG 2.69 2.62 P P 1.39 2.18 E M 7 . 9 1 
992 91 69 6 RF 119 1 LSG 2.79 2.87 cyt P 2.24 1.47 EHNV7.91 
993 91 60 7 RF 119 1 LSG 1.89 2.93 cyt P 2.87 1.99 EHNV7.91 
994 91 69 8 RF 119 1 LSG 9.89 2.41 cyt P 2.73 1.67 EHNV7,31 
995 91 69 9 RF 119 1 LSG 1.97 3.19 cyt P 2.82 2.19 EHNV7.91 
996 91 69 18 RF 119 1 LSG 2.94 2.77 cyt P 2.62 2.91 EHNV7.91 
997 91 69 11 RF 119 1 LSG 2.82 2.88 P n 9.78 9.28 EHNV7.91 
998 91 69 12 RF 119 1 LSG 2.84 2.86 P P 1.71 2.99 EHNV7.91 
1997 92 28 13 RT 119 1 LKS 8.89 9.22 cyt P 9.88 1.59 EHNV1.92 
1998 92 28 14 RT 119 1 LKS 9.66 1.29 cyt P 9.32 1.93 EhNVl.92 
1159 91 69 13 RF 119 1 LSG cyt P 2.74 2.11 EHNV7.91 
1169 91 69 14 RF 119 1 LSG cyt P 2.84 2.28 EHNV7.91 
EHNV FREE POPULATIONS 
1 99 RF 18 ] i L 9.13 n n n 
3 99 RF 18 1 L 9.29 n n n 
5 91 a RF 39 L 9.15 n n n 
6 91 b RF 39 L 9.13 n n n 
? 91 RF 39 L 9.23 n n n 
8 91 a RF 39 1 9.13 n n n 
9 91 b RF 39 L 9.21 n n n 
19 91 RF 39 L 9,13 n n n 
66 99 1 RF 56 5 LS 9.28 n n n 
67 99 2 RF 56 5 LS 9.14 n n n 
68 99 3 RF 56 ! 5 LS 9.12 n n n 
9 . 3 5 9 . 2 3 9 . 3 2 
9 . 2 4 9 . 2 3 9 . 3 9 












Key Yr No Sub S p e c i e s Exp P o o l Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 0dp4 OdpS 
0 . 2 6 
Comment1 
69 90 25 4 RF 56 5 LS 0 . 1 7 n n n 0 . 2 3 0 . 2 2 Khancoban 
79 90 25 5 RF 56 5 LS 0 . 1 3 n n n 0 . 2 4 9 . 2 3 0 . 2 9 Khancoban 
71 90 25 6 RF 56 5 LS 0 . 0 8 n n n 0 . 1 9 9 . 2 3 9 . 3 9 Khancoban 
72 90 25 7 RF 56 S LS 0 . 1 1 n n n 0 .17 9 . 2 1 9 . 3 1 Khancoban 
73 90 25 8 RF 56 5 LS 0 . 1 5 n n n 0 . 2 1 9 . 2 2 0 . 2 7 Khancoban 
74 90 25 9 RF 56 LS 0 . 1 6 n n n 0 . 2 4 9 . 2 2 0 . 2 8 Khancoban 
75 90 25 10 RF • 55 5 LS 0 . 1 5 n n n 0 . 2 1 0 . 2 9 0 . 2 7 Khancoban 
78 90 25 11 RF 56 5 LS 0 . 2 0 n n n 0 .22 9 . 2 1 0 . 2 6 Khancoban 
77 90 25 12 RF 56 5 LS 0 . 1 4 n n n 0 .22 9 . 2 1 0 . 4 7 Khancoban 
78 90 25 13 RF 56 5 LS 0 . 0 7 • n n n 0 . 2 1 0 . 2 0 0 . 3 2 Khancoban 
79 90 25 1 14 RF 56 5 LS 0 . 1 9 n n n 0 . 1 9 0 . 1 8 0 . 3 3 Khancoban 
80 90 h 15 RF 56 5 LS 0 . 1 6 n n n 0 .19 0 . 2 3 0 . 3 0 Khancoban 
81 90 25 16 RF 56 5 LS 0 . 0 9 n n a 0 .14 9 . 2 9 0 . 3 3 Khancoban 
82 90 25 17 RF 56 5 LS 0 . 1 7 n n n 0 .22 9 . 2 0 0 . 3 0 Khancoban 
83 90 25 18 RF 56 5 LS 0 . 1 5 n n n 0 . 2 4 0 . 1 8 0 . 2 9 Khancoban 
84 90 25 19 RF 56 5 LS 0 . 1 0 n n n 0 . 2 3 0 . 2 0 0 . 3 0 Khancoban 
85 90 25 20 RF 56 5 LS 0 . 2 0 n n n 0 . 2 1 0 . 2 9 0 . 2 8 Khancoban 
86 90 25 21 RF 56 5 LS 0 . 1 0 n n n 0 .27 0 .17 9 . 3 3 Khancoban 
87 90 25 22 RF 56 5 LS 0 . 1 2 n n n 0 . 2 0 9 . 1 8 9 . 3 1 Khancoban 
88 90 25 23 RF 56 5 LS 0 . 0 9 n n n 0 . 1 3 0 . 2 1 9 . 3 1 Khancoban 
89 90 25 24 RF 56 5 LS 0 . 2 4 n n n 0 . 2 3 0 . 2 0 0 . 3 3 Khancoban 
90 90 25 25 RF 56 5 LS 0 . 1 4 n n n 0 . 2 2 0 . 2 3 0 . 2 8 Khancoban 
91 90 25 26 RF 56 5 LS 0 . 1 7 n n n 8 . 2 8 0 . 1 9 0 . 3 1 Khancoban 
92 90 25 27 RF 56 5 LS 0 . 1 6 n n n 9 . 2 3 0 . 2 2 0 . 3 9 Khancoban 
93 90 25 28 RF 56 5 LS 0 . 1 1 n n n 0 . 2 6 0 . 1 9 0 . 2 8 Khancoban 
94 90 25 29 RF 56 5 LS 0 . 0 7 n n n 0 .22 0 . 1 8 0 . 2 8 Khancoban 
95 90 25 30 RF 56 5 LS 0 . 0 8 n n n 0 .22 0 . 1 6 0 . 2 7 Khancoban 
96 91 26 a l RF 65 4 LS 0 ; 0 9 n n n 0 .20 0 . 2 0 0 . 2 2 ACT 
97 91 26 b l RF 55 5 LS 0 . 1 5 n n n 0 .16 9 . 2 3 0 . 2 4 ACT 
98 91 26 b2 RF 65 1 3 LS 0 . 1 4 n n n 0 .18 9 .27 0 . 2 3 ACT 
99 91 26 c l RF 65 ! 3 LS 0 . 0 8 n n n 0 .20 9 . 2 6 0 . 2 5 ACT 
100 91 26 c2 RF 65 ! 3 LS 0 . 1 1 n n n 0 .17 9 . 2 3 0 . 2 2 ACT 
101 91 26 c3 RF 65 1 3 LS 0 . 0 9 n n n 0 .16 9 . 2 3 0 . 2 4 ACT 
102 91 26 c4 RF 65 1 5 LS 0 . 0 8 n n n 9 .20 9 .20 0 . 2 1 ACT 
103 91 26 d l RF 65 5 LS 0 . 1 5 n n n 9 . 1 8 9 . 2 4 0 . 2 1 ACT 
104 91 26 • d2 RF 65 5 LS 0 . 1 3 n n n 3 .14 3 . 2 1 0 . 2 3 ACT 
105 91 26 e l RF 65 5 K 0 . 0 8 n n n 0 . 2 1 0 . 2 8 0 . 2 5 ACT 
106 91 26 e2 RF 65 5 K 0 . 0 6 n n n 0 .19 0 . 2 6 0 . 2 5 ACT 
107 91 25 e3 RF 65 5 K 0 . 0 9 n n n 0 .25 9 .26 0 .22 ACT 
108 91 26 e4 RF 65 5 K 0 . 1 0 n n n 3 .24 9 .22 0 . 2 2 ACT 
109 91 26 f l RF 65 5 LS 0 . 0 8 n n n 9 .39 9 .32 0 . 2 8 ACT 
110 91 26 f 2 RF 65 5 LS 0 . 0 6 n n n 0 . 3 1 9 . 3 5 0 . 3 4 ACT 
111 91 26 f 3 RF 65 5 LS 0 . 0 7 n n n 9 .26 9 . 3 1 0 . 2 3 ACT 
112 91 26 f 4 RF 65 5 LS 0 . 0 8 n n n 0 .30 9 . 2 8 0 . 3 1 ACT 
113 91 26 f 5 RF 55 5 LS 0 . 0 8 n n n 0 . 3 3 9 . 2 8 0 . 3 0 ' ACT 
114 91 26 f 6 RF 65 5 LS 0 . 0 8 n n n 9 .29 0 .27 ' ' ACT 
115 91 26 f 7 RF 65 5 . LS 0 . 0 8 n n n 0 . 3 1 9 . 3 2 0 . 2 6 ACT 
116 91 26 f 8 RF 65 5 LS 0 . 0 9 n n n 9 . 2 5 0 . 6 4 ACT 
117 91 26 f 9 RF 65 5 LS 0 . 1 1 n n n 9 .29 0 . 2 3 9 . 5 4 ACT 
118 91 26 f l 0 RF 65 5 LS 0 . 0 7 n n n 9 .34 9 . 3 1 9 . 6 4 ACT 
119 91 26 f l l RF 65 5 LS 0 . 0 7 n n n 9 .29 9 . 2 7 9 . 6 8 ACT 
120 91 26 f l 2 RF 65 3 LS 0 . 1 0 n n n 3 .33 9 . 5 9 ACT 
Key Yr No Sub Species Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 Odp5 Cominentl 
121 91 26 fl3 RF 65 3 LS 0.09 n n n 0.32 0.31 0.70 ACT 
122 91 26 9l RF 65 5 LS 8.08 n n n 0.18 0.36 0.63 ACT 
123 91 26 g2 RF 65 5 LS 0.89 n n n 0.23 0.58 ACT 
124 91 26 hi - RF 65 3 LS 0.09 n n n 0.25 8.26 0.50 ACT 
125 91 26 il RF 65 5 LS 0.08 n n n 0.20 0.20 0.58 ACT 
126 91 26 i2 RF 65 5 LS 0.10 n n n 0.16 0.21 8.61 ACT 
127 91 26 i3 RF • 65 5, LS 0.08 n n n 0.17 0.28 0.52 ACT 
128 91 26 14 RF 65 5 LS 0.09 n n n 0.16 0.25 0.49 ACT 
129 91 26 jl RF 65 5 LS 0.08 n n n 0.20 0.24 0.61 ACT 
130 91 26 j2 RF 65 5 LS 0.08 • n n n 0.21 0.30 0.63 ACT 
131 91 26 1 j3 RF 65 4 LS 0.11 n n n 0.23 0.27 0.59 ACT 
132 91 26 kl RF 65 5 LS 0.09 n n n 0.36 8.25 0.52 ACT 
133 91 26 k2 RF 65 5 LS 0.06 n n n 0.40 0.19 0.51 ACT 
134 91 26 k3 RF 65 5 LS 0.06 n n n 0.31 0.28 0.61 ACT 
135 91 26 k4 RF 65 4 LS 0.07 n n n 0.29 0.21 0.62 ACT 
136 91 26 11 RF 65 5 LS 0.07 n n n 8.24 0.21 0.55 ACT 
137 91 26 12 RF 65 5 LS 0.06 n n n 0.27 0.24 0.67 ACT 
138 91 26 13 RF 65 3 LS 0.06 n n n 0.26 0.22 0.59 ACT 
178 90 19 RT 75.86 3 LS 0.10 cyt n n 0.18 Gaden 
179 90 20 RF 75.86 1 LS 0.17 cyt n n 0.21 0.59 RFl, RF2 
181 90 27 RF 75.86 1 LS 0.16 cyt n n 0.21 0.47 ACT 
192 91 5 RT 75.86 1 LS 0.25 n n n 0.13 0.53 Stock EMAl 
193 91 12 RT 75.86 1 LS 0.23 n n n 0.16 0.43 Stock EHAI 
194 91 17 RF 75.86 2 LS 0.33 cyt n n 0.19 0.53 Stock EMAl 
195 91 20 RF 75.86 1 LS 0.25 n n n 0.23 0.47 Stock EMAl 
197 91 3E»05 RT 75.36 3 LS 0.09 n n n 0.22 0.46 Stock EMAl 
198 91 40 RF 75.86 1 LS 0.14 n n n 0.18 0.43 Stock EMAl 
280 91 56 a RF 75.86 3 LS 0.12 cyt n n 0.16 8.44 Stock EMAl 
291 91 56 b RF 75.86 2 LS 0.07 n n n 0.17 0.51 Stock EMAl 
202 91 10 RF 75.86 1 LS 0.09 cyt n n 0.18 0.40 Stock EMAl 
204 90 19 a RT 75.86 3 LS 0.11 cyt n n 0.19 0.41 Gaden, stock at EMAl 
205 90 19 b RT 75.86 3 LS 0.11 cyt n n 8.18 0.43 Gaden, stock at EMAl 
206 90 19 c RT 75.86 3 LS 0.11 cyt n n 0.10 0.44 Gaden, stock at EMAl 
233 91 69 A RT 100 1 L 0.39 cyt n 1.05 0.52 Gaden 
234 91 69 B RT 100 1 L 0.52 cyt n 8.75 0.33 Gaden 
236 91 75 RT 100 1 L 0.30 cyt n 0.56 0.31 Gaden 
237 91 87 RT 100 1 L 0.32 cyt n 0.71 0.33 Gaden 
284 92 9 1 RT 113 5 LKS 0.69 0.22 cyt n 0.21 0.23 Gaden 
285 92 9 1 RT 113 0.38 0.18 Gaden 
286 92 9 1 RT 113 0.63 0.23 Gaden 
287 92 9 1 RT 113 0.69 0.18 Gaden 
288 92 9 1 RT 113 0.75 0.21 Gaden 
289 92 9 6 RT 113 5 LKS 0.60 0.15 cyt n 0.22 0.20 Gaden 
290 92 9 6 RT 113 0.74 0.16 Gaden 
291 92 9 6 RT 113 0.65 0.15 • Gaden 
292 92 9 6 RT 113 1.12 0.19 ' Gaden 
293 92 9 RT 113 1.07 0.17 Gaden 
294 92 9 11 RT 113 5 LKS 0.69 0.20 cyt n 0.22 9.19 Gaden 
295 92 9 11 RT 113 0.52 0.16 Gaden 
296 92 9 11 RT 113 0.79 8.20 Gaden 
297 92 9 11 RT 113 0.90 0.18 Gaden 
298 92 9 11 RT 113 0.80 0.17 Gaden 
Key Yr No Sub S p e c i e s Exp P o o l Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl 
299 92 9 16 RT 113 S LKS 8 . 5 3 8 .12 c y t n 8 .21 
366 92 9 16 RT I r - 8 . 8 2 8 .19 
381 92 9 16 RT i n 8 . 8 8 8 .18 
382 92 9 16 'RT 113 8 .67 8 . 1 5 
383 92 9 16 RT 113 8 . 7 1 6 . 1 4 
384 92 9 21 RT 113 5 i LKS 8 . 6 5 8 .18 c y t n 8 .22 
385 92 9 21 RT 113 8 . 5 4 8 .17 
386 92 9 21 RT 113 8 . 7 3 8 . 1 5 
387 92 9 21 RT 113 8 . 7 3 8 . 1 5 
388 92 9 21 RT 113 8 . 8 8 8 .19 
383 92 9 V 26 RT 113 5 LKS 8 . 6 2 8 .19 c y t n 8 .22 
318 92 9 26 RT 113 8 . 5 6 8 .19 
311 92 9 26 RT 113 8 . 6 1 8 . 2 6 
312 92 9 26 RT 113 8 . 5 4 8 . 1 8 
313 92 9 26 RT 113 8 . 7 5 6 . 1 7 
314 92 9 31 RT 113 S ; LKS 8 . 6 6 8 . 1 5 c y t n 8 .21 
315 92 9 31 RT 113 8 . 5 8 8 . 1 5 
315 92 9 31 RT 113 8 . 8 2 8 .28 
31? 92 9 31 RT 113 8 . 6 4 6 .17 
313 . 92 9 31 RT 113 8 . 5 8 8 . 2 8 
319 92 9 36 RT 113 5 LKS 6 . 8 8 6 .26 c y t n 8 .28 
328 92 9 36 RT 113 8 . 6 9 8 . 2 3 
321 92 9 36 RT 113 8 . 5 9 8 . 1 4 
322 92 9 36 RT 113 8 . 7 6 6 .16 
323 92 9 36 RT 113 8 . 4 2 8 . 1 5 
324 92 9 41 RT 113 5 LKS 6 . 6 5 8 . 2 3 c y t n 8 .21 
325 92 9 41 RT 113 8 . 9 2 8 . 2 1 
326 92 9 41 RT 113 8 . 6 4 8 . 2 4 
327 92 9 41 RT 113 8 . 4 9 8 . 2 3 
328 92 9 41 RT 113 8 . 8 5 8 .28 
329 92 9 46 RT 113 5 LKS 8 . 6 7 8 . 2 5 c y t n 8 .22 
338 92 9 46 RT 113 8 . 5 9 8 .18 
331 92 9 46 RT 113 6 . 7 8 8 .18 
332 92 9 46 RT 113 8 . 7 4 8 .26 
333 92 9 46 RT 113 8 . 6 4 6 . 2 1 
334 92 9 • 51 RT 113 5 LKS 8 . 8 9 8 .22 c y t n 8 .24 
335 92 9 51 RT 113 8 . 6 1 6 . 2 2 
336 92 9 51 RT 113 1 . 8 4 6 .28 
337 92 9 51 RT 113 8 . 7 3 8 . 2 6 
338 92 9 51 RT 113 8 . 7 5 8 .19 
339 92 9 56 RT 113 5 LKS 8 . 5 2 8 . 1 3 c y t n 8 .28 
348 92 9 56 RT 113 8 . 5 8 8 . 2 8 
341 92 9 56 RT 113 8 . 8 1 8 . 2 4 
342 92 9 55 RT 113 8 . 3 9 6 .18 
343 92 9 55 RT 113 8 . 8 1 6 . 1 5 
344 92 9 61 RT 113 5 LKS 8 . 6 3 8 . 2 5 c y t n 0 .21 
345 92 9 61 RT 113 8 . 4 8 8 .17 
34S 92 9 51 RT 113 8 . 5 4 8 .19 
347 92 1 3 61 RT 113 8 . 6 7 6 . 2 1 
348 92 9 61 RT 113 8 . 1 2 8 . 1 2 
349 92 ' ] 65 RT 113 5 LKS 8 . 6 7 8 . 2 2 c y t n 8 .22 






















































Key Yr No Sub Species Exp Pool Organ Odn Od Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 Odp5 Comment 1 351 92 9 66 RT 113 9.59 9 Gaden 
352 92 9 66 RT 113 9.54 9 Gaden 
353 92 9 66 RT 113 9.61 9 Gaden 
354 92 9 71 RT 113 5 LKS 9.19 9 cyt n 8.29 9.19 Gaden 
355 92 9 71 RT 113 9.36 9 Gaden 
356 92 9 71 RT 113 9.48 9 Gaden 
357 92 9 71 RT 113 9.53 9 Gaden 
358 92 9 71 RT 113 9.49 9 Gaden 
359 92 9 76 RT 113 5 LKS 9.49 9 cyt n 9.22 9.19 Gaden 
369 92 9 76 RT 113 9.62 9 Gaden 
361 92 9 ^ 76 RT 113 9.54 9 Gaden 
362 92 9 76 RT 113 9.85 8 Gaden 
363 92 9 76 RT 113 9.89 9 Gaden 
364 92 9 81 RT 113 5 LKS 9.76 9 cyt n 9.21 9.29 Gaden 
365 92 9 81 RT 113 9.59 9 Gaden 
366 92 9 81 RT 113 9.39 9 Gaden 
367 92 9 81 RT 113 9.47 9 Gaden 
368 92 9 81 RT 113 9.29 9 Gaden 
363 92 9 86 RT 113 5 LKS 9.23 9 cyt n 9.22 9.29 Gaden 
379 92" 9 86 RT 113 9.96 9 Gaden 
371 92 9 86 RT 113 9.54 9 Gaden 
372 92 9 86 RT 113 9.74 9 Gaden 
373 92 9 86 RT 113 9.74 9 Gaden 
374 92 9 91 RT 113 5 LKS 9.29 9 cyt n 9.29 9.19 Gaden 
375 92 9 91 RT 113 9.21 9 Gaden 
376 92 9 91 RT 113 9.55 9 Gaden 
377 92 9 91 RT 113 9.41 9 Gaden 
378 92 9 91 RT 113 9.47 9 Gaden 
379 92 9 96 RT 113 5 LKS 9.43 9 cyt n 9.22 9.21 Gaden 
389 92 9 96 RT 113 9.74 9 Gaden 
381 92 9 96 RT 113 9.79 9 Gaden 
382 92 9 96 RT 113 9.47 9 Gaden 
383 92 9 96 RT 113 9.35 9 Gaden 
1993 92 25 PI RT 119 5 LKS 9.19 9 cyt n 9.18 0.23 Tasmania 
1919 92 25 PI RT 113 9.99 9 Tasmania 
1911 92 25 • PI RT 119 9.17 9 Tasmania 
1912 92 25 PI RT 119 9.99 9 Tasmania 
1913 92 25 PI RT 119 9.99 9 Tasmania 
1914 92 25 P2 RT 119 5 LKS 9.14 9 cyt n 9.18 9.22 Tasmania 
1915 92 25 P2 RT 119 9.25 9 Tasinania 
1916 92 25 P2 RT 119 9.99 9 Tasmania 
1917 92 25 P2 RT 113 9.12 9 Tasmania 
1918 92 25 P2 RT 119 9.96 9 Tasmania 
1919 92 25 P3 RT 119 5 LKS 9.25 9 cyt n 8.16 8.21 Tasmania 
1929 92 25 P3 RT 119 9.99 9 • Tasmania 
1321 92 25 P3 RT 119 9.98 9 ' r Tasmania 
1922 92 25 P3 RT 119 9.28 9 Tasmania 
1923 92 25 P3 RT 113 9.14 9 Tasmania 
1924 92 25 P4 RT 119 5 LKS 9.11 9 cyt n 9.16 9.21 Tasmania 
1925 92 25 P4 RT 113 9.13 9 Tasmania 
1926 92 25 P4 RT 119 9.97 9 Tasmania 
1927 92 25 P4 RT 119 9.17 9 Tasmania 
Key Yr No Sub Species Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 Odp5 Comment1 
1028 92 25 P4 RT 119 0.21 0.17 Tasmania 
1929 92 25 P5 RT 119 5 LKS 0.25 0.16 cyt n 0.16 9.22 Tasmania 
1039 92 25 P5 RT 119 0.10 9.13 Tasmania 
1031 92 25 P5 RT 119 0.13 9.13 Tasmania 
1032 92 25 P5 RT 119 0.11 0.11 Tasmania 
1033 92 25 P5 RT 119 0.10 0.12 Tasmania 
1034 92 25 P6 RT • 119 5 LKS 0.08 0.09 cyt n 0.17 9.21 Tasmania 
1035 92 25 P6 RT 119 0.10 0.07 Tasmania 
1038 92 25 P6 RT 119 0.14 0.16 Tasmania 
1037 92 25 P6 RT 119 0.09 0.13 Tasmania 
1038 92 251 P6 RT 119 0.10 0.14 Tasmania 
1039 92 25' P7 RT 119 5 LKS 0.08 0.09 cyt n 3.18 9.16 Tasmania 
1049 92 25 P7 RT 119 0.09 0.14 Tasmania 
1041 92 25 P7 RT 119 0.35 0.16 Tasmania 
1042 92 25 P7 RT 119 0.09 0.12 Tasmania 
1043 92 25 P7 RT 119 0.41 0.17 Tasmania 
1944 92 25 P8 RT 119 5 LKS 0.08 0.13 cyt n 0.19 9.16 Tasmania 
1045 92 25 P8 RT 119 0.09 0.12 Tasmania 
1945 92 25 P8 RT 119 0.16 0.15 Tasmania 
1947 92 25 P8 RT 119 0.38. 0.17 Tasmania 
1948 92 25 P8 RT 119 0.23 9.20 Tasmania 
1049 92 25 P9 RT 119 5 LKS 0.09 9.11 cyt n 0.18 9.17 Tasmania 
1050 92 25 P9 RT 119 0.10 9.13 Tasmania 
1051 92 25 P9 RT 119 0.99 9.99 Tasmania 
1052 92 25 P9 RT 119 0.14 9.18 Tasmania 
1053 92 25 P9 RT 119 0.19 9.13 Tasmania 
1054 92 25 P10 RT 119 5 LKS 0.11 9.15 cyt n 0.19 9.15 Tasmania 
1055 92 25 P10 RT 119 0.28 9.18 Tasmania 
105S 92 25 P10 RT 119 0.21 9.17 Tasmania 
1057 92 25 P10 RT 119 0.98 9.15 Tasmania 
1058 92 25 P19 RT 119 0.54 9.18 Tasmania 
1959 92 25 Pll RT 119 5 LKS 0.98 9.99 cyt n 0.18 9.16 Tasmania 
I960 92 25 Pll RT 119 9.98 9.19 Tasmania 
1061 92 25 Pll RT 119 9.11 9.14 Tasmania 
1062 92 25 Pll RT 113 9.98 9.08 Tasmania 
1063 92 25 •pil RT 119 9.10 9.13 Tasmania 
1064 92 25 P12 RT 119 5 LKS 0.16 9.17 cyt n 3.15 9.18 Tasmania 
1065 92 25 P12 RT 119 0.08 0.98 Tasmania 
1066 92 25 P12 RT 119 0.10 9.12 Tasmania 
1067 92 25 P12 RT 119 0.24 9.11 Tasmania 
1068 92 25 P12 RT 119 0.27 9.29 Tasmania 
1969 92 25 P13 RT 119 5 LKS 0.11 9.13 cyt n 9.20 9.17 Tasmania 
1070 92 25 P13 RT 119 0.11 9.14 Tasmania 
1971 92 25 P13 RT 119 0.10 0.13 Tasmania 
1072 92 25 P13 RT 113 9.33 9.20 * Tasmania 
1073 92 25 P13 RT 119 9.11 9.15 < f Tasmania 
1074 92 25 P14 RT 119 5^ LKS 9.11 0.09 cyt n 9.19 0.16 Tasmania 
1075 92 25 P14 RT 119 0.24 0.16 Tasmania 
1076 92 25 P14 RT 119 0.13 0.13 Tasmania 
1077 92 25 P14 RT 119 9.97 0.09 Tasmania 
1078 92 25 P14 RT 119 9.18 9.15 Tasmania 
1079 92 25 P15 RT 119 5 LKS 9.09 9.20 cyt n 3.18 0.16 Tasmania 
Key Yr No Sub Species Exp Pool Organ Odn 0 Vpl Vp2 Vp3 Vp4 Vp5 Odpl 0(jp2 Odp3 Odp4 Odp5 Comment1 
1989 92 25 P15 RT 119 9.19 9 Tasmania 
1081 92 25 P15 RT 119 9.13 9 Tasmania 
1982 92 25 P15 RT 113 9.19 9 Tasinania 
1983 92 25 P15 RT 113 9.11 9 Tasmania 
1984 92 25 P16 RT 113 5 LKS 9.15 9 cyt lì 0.15 0.15 Tasmania 
1985 32 25 P16 RT 113 9.17 9 Tasmania 
1985 92 25 P16 RT • 119 9.11 9 Tasmania 
1987 32 25 P15 RT 119 8.12 9 Tasmania 
1988 92 25 P16 RT 113 9.12 9 Tasmania 
1989 92 25 P17 RT 113 5 LKS 9.11 9 cyt n 0.13 9.25 Tasmania 
1999 92 25 P17 RT 113 9.23 9 Tasmania 
1991 92 h P17 RT 113 0.12 0 Tasmania 
1992 92 25 P17 RT 113 9.13 0 Tasmania 
1993 92 25 P17 RT 119 9.14 9 Tasmania 
1934 92 25 P18 RT 119 5 LKS 9.99 9 cyt n 0.17 0.20 Tasmania 
1995 92 25 P18 RT 119 9.13 9 Tasmania 
1996 92 25 P18 RT 119 9.33 9 Tasmania 
1997 92 25 P18 RT 113 9.33 9 Tasmania 
1998 92 25 P18 RT 113 9.11 9 Tasmania 
1999 92 25 P13 RT 113 5 LKS 0.14 0 cyt n 0.16 0.16 Tasmania 
1199 92 25 P19 RT 113 0.31 0 Tasmania 
1191 92 25 P19 RT 113 0.46 Tasmania 
1192 92 25 P19 RT 113 9.99 Tasmania 
1193 92 25 P19 RT 113 9.10 Tasmania 
1194 92 25 P29 RT 113 5 LKS 0.11 cyt n 0.17 0.19 Tasmania 
1195 92 25 P29 RT 119 0.20 Tasmania 
1196 92 25 P29 RT 113 0.11 Tasmania 
1197 92 25 P20 RT 119 0.12 Tasmania 
1198 92 25 P28 RT 113 0.31 Tasmania 
1199 92 25 P21 RT 119 5 LKS 0.13 cyt n 8.19 8.17 Tasmania 
1119 92 25 P21 RT 119 0.46 Tasmania 
nil 92 25 P21 RT 119 0.09 Tasmania 
1112 92 25 P21 RT 113 9.12 Tasmania 
1113 92 25 P21 RT 113 0.43 Tasmania 
1114 92 25 P22 RT 113 5 LKS 0.14 cyt n 0.18 9.16 Tasmania 
1115 32 25 •P22 RT 113 0.25 Tasmania 
1116 32 25 P22 RT 113 0.16 Tasmania 
1117 32 25 P22 RT 119 9.23 Tasmania 
1118 32 25 P22 RT 119 0.18 Tasmania 
1119 92 25 P23 RT 119 5 LKS 0.14 cyt n 9.17 3.15 Tasmania 
1129 92 25 P23 RT 119 0.14 ) Tasmania 
1121 92 25 P23 RT 119 0.11 Tasmania 
1122 32 25 P23 RT 113 0.33 Tasmania 
1123 32 25 P23 RT 113 0.30 Tasmania 
1124 32 25 P24 RT 113 c <J LKS 0.15 cyt n 0.22 9.13 Tasmania 
1125 92 25 P24 RT 113 0.23 ' r Tasmania 
1126 32 25 P24 RT 113 0.31 Tasmania 
1127 92 25 P24 RT 119 0.20 Tasmania 
1123 92 25 P24 RT 119 0.13 Tasmania 
1129 92 25 P25 RT 113 5 LKS 0.15 cyt n 0.23 3.18 Tasmania 
1139 92 25 P25 RT 113 0.31 Tasmania 
1131 92 25 P25 RT 113 0.38 Tasmania 
Key Yr No Sub Species Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Vp4 Vp5 Odpl Odp2 Odp3 Odp4 Odp5 Codimentl 1132 92 25 P25 RT 119 9.30 0.19 Tasmania 
1133 92 25 P25 RT 119 9.29 0.15 Tasmania 
92 25 P26 RT 119 5 LKS 9.18 0.13 cyt n 0.19 0.18 Tasmania 
92 25 P28 - RT 119 0.17 0.13 Tasmania 
92 25 P26 RT 119 9.19 9.16 Tasmania 
92 25 P26 RT 119 9.27 0.18 Tasmania 
1138 92 25 P25 RT 119 0.19 0.15 Tasmania 
92 25 P27 RT 119 5 LKS 9.13 0.09 cyt n 3.15 9.15 Tasmania 
1140 92 25 P21 RT 119 9.27 0.18 Tasmania 
92 25 P27 RT 119 0.24 0.17 Tasmania 
92 25 P2'i RT 119 9.21 0.15 Tasmania 
1143 92 25 P27 RT 119 9.24 9.17 Tasmania 
92 25 P28 RT 119 5 LKS 9.17 9.14 cyt n 0.19 0.29 . Tasmania 
92 25 P28 RT 119 9.12 9.11 Tasmania 
92 25 P28 RT 119 9.23 9.15 Tasmania 
92 25 P28 RT 119 9.19 9.17 Tasmania 
1148 92 25 P28 RT 119 9.13 0.19 Tasmania 
92 25 P29 RT 119 5 LKS 9.12 9.17 cyt n 9.17 9.21 Tasmania 
1158 92 25 P29 RT 119 9.14 9.18 Tasmania 
92 25 P29 RT 119 9.29 9.17 Tasmania 
92 25 P29 RT 119 9.14 9.21 Tasmania 
92 25 P29 RT 119 8.12 0.17 Tasmania 
92 25 P39 RT 119 5 LKS 9.14 9.18 cyt n 0.18 9.19 Tasmania 
1155 92 25 P39 RT 119 0.19 0.15 Tasmania 
92 25 P39 RT 119 9.17 0.16 Tasmania 
92 25 P30 RT 119 0.11 0.14 Tasmania 
1158 92 25 P39 RT 119 0.15 0.16 Tasmania 
APPENDIX C 
Records of 18 honogenates iron infected populations with positive ELISA but negative virus isolation results 
Key Yr No Sub Species Exp Pool Organ Odn Odd Vpl Vp2 Vp3 Odpl Odp2 Cdp3 CoDBentl 
21 90 24 11 RF 56 5 IS 1.05 n n n 0.15 Blowering 
180 90 21 RF 75.86 4 2.55 cyt n n 1.15 0.54 EHNV2.91 
182 91 2 5 RF 75.86 3 LS 2.57 n n Q 1.48 0.50 Burrinjuck 
184 91 2 7 RF 75.86 3 LS 2.34 cyt n n 1.20 0.59 Burrinjuck 
m 91 2 d3 RF 75.86 3 LS 1.99 n n n 1.30 0.50 Burrinjuck 
191 91 2 14 RF 75.86 4 LS 2.11 cyt n n 1.70 0.57 Burrinjuck 
207 91 39 1 RT 100 1 L 2.74 n n n 2.78 0.76 EHNV2.91 
208 91 39 2 RT 100 1 L 2.54 n n 1.22 0.34 EHMV2.91 
252 91 82 3A SG 100 1 G 2.51 cyt n 2.54 0.45 ACT bird 
260 91 82 6A SG 100 1 G 2.65 cyt n 2.62 0.89 ACT bird 
270 91 82 9B SG 112 1 G 2.77 2.54 cyt n 1.13 0.33 ACT bird 
272 91 82 10B SG 112 1 G 2.01 0.32 cyt n 0.34 0.26 ACT bird 
273 91 82 10C SG 112 1 G 1.36 0.23 cyt n 0.21 0.21 ACT bird 
283 92 11 5 RT 112 1 LKS 2.55 2.37 cyt n 1.29 2.60 SHT 
7 U 92 17 P16 RT 117 5 LKS 1.47 0.18 n n 0.27 0.20 SHT 
759 92 17 P19 RT 117 5 LKS 1.29 0.36 a n 0.19 0.19 SHT 
764 92 17 P20 RT 117 5 LKS 1.35 0.19 n n 0.19 0.18 SKT 
1000 92 28 PI RT 119 5 LKS 1.93 1.16 cyt n 0.23 0.21 EHNV1.92 
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